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ABSTRACT
Ambient air pollutants are one of the most harmful environmental stressors to human 
health. During the last decades, different ambient particulate and gaseous pollutants have 
been studied, and in numerous studies fine particles (< 2.5 µm in aerodynamic diameter, 
PM2.5) and larger, inhalable particles (< 10 µm, PM10) have been associated with excess 
morbidity and mortality. Particle size and composition are likely to affect the toxicity of 
particles. The composition of particles varies as they are emitted from different sources. 
However, the health effects of different types of ambient particles have rarely been 
determined because of the lack of measurement data.
The aim of this thesis was to study the components of ambient air pollution that may 
explain the short-term health effects associated with the changes in the levels of air pollution. 
Particles in different size fractions, gaseous pollutants such as ozone (O3), nitrogen dioxide 
(NO2), and carbon monoxide (CO), and PM2.5 emitted from different sources were studied. 
The health effects studied were cause-specified daily mortality and hospital admissions for 
cardiorespiratory causes, and emergency room visits for asthma and chronic obstructive 
pulmonary disease (COPD). To establish possible differences in the sensitivity to air 
pollutants, the analyses were done separately for three age groups: children under 15 years 
of age, adults aged 15–64 years, and the elderly aged 65 years or older.
All the data was collected during 1998–2004 from Helsinki metropolitan area, which 
consists of four municipalities: Helsinki, Vantaa, Espoo and Kauniainen. Mass and count 
of ambient particles and concentrations of gaseous pollutants were measured at central 
measurement sites in Helsinki, except for O3 that was monitored at a suburban station. 
Fine particulate mass (PM2.5) was apportioned between four sources: traffic, long-
range transport, soil, and coal/oil combustion. Daily mortality, hospital admission, and 
emergency room visit counts were obtained from national registers.
The mean (SD) daily levels of PM2.5 in Helsinki were 9 (5.8) µg/m
3. More than half 
of the PM2.5 mass was long-range transported, a fifth was from local traffic, and the rest 
was from soil, coal/oil combustion, and unidentified sources. The mean (SD) counts of 
ultrafine particles (UFP, < 0.1 µm) and accumulation mode particles (0.1–0.3 µm) were 
8 203 (5 137) and, 359 (261) 1/cm3, respectively. The mean (SD) concentration of coarse 
particles (2.5–10 µm), NO2, CO, and O3 were 9.9 (8.3) µg/m
3, 28 (11.3) µg/m3, 0.5 
(0.2) mg/m3, and 71 (20) µg/m3, respectively.
Increases in daily levels of traffic-related pollutants (UFP, NO2, CO) and O3 were 
associated with increased asthma emergency room visits among children. Among the 
elderly, especially accumulation mode particles and PM2.5, but also coarse particles, were 
associated with all respiratory, pneumonia and pooled asthma-COPD morbidity. Traffic-
related and long-range transported PM2.5, but also PM2.5 from soil was associated with 
the respiratory morbidity of the elderly. Among children, the associations with ultrafine 
particles had a delay of 3–5 days, whereas among the elderly the associations were more 
immediate. Pooled asthma-COPD hospital admissions of the elderly were also increased 
in association with O3. Few associations were observed among adults.
Overall, few associations between cardiovascular outcomes and ambient pollutants 
were observed. However, total cardiovascular and stroke mortality, but not stroke 
morbidity, among the elderly was associated with the increase in PM2.5 during the warm 
season. There was also some suggestion of an association between arrhythmia admissions 
and PM2.5. 
The current results agree with earlier studies showing the effect of particulate air 
pollution and ozone on increased daily respiratory mortality and morbidity. Although few 
associations were observed for cardiovascular outcomes in the present study, these results 
together with results from earlier international studies and Finnish panel studies suggest 
the importance of particulate air pollution also in Helsinki, especially among individuals 
with underlying cardiorespiratory disease. Accumulation mode particles and PM2.5 have 
more associations with different outcomes than other particle fractions. This may partly 
be due to better exposure assessment of these particles compared to ultrafine and coarse 
particles. Of the PM2.5 sources, traffic and long-range transported PM2.5 have the strongest 
effects on respiratory health, but also soil-derived particles seem to be harmful. Ultrafine 
particles and NO2 are considered as markers of traffic pollutants, and in this study, it 
was not possible to identify the causal component of traffic emissions responsible for the 
observed effects among children. Overall, adults seem to be less sensitive to the effects of 
ambient pollutants than children and the elderly. 
In summary, the effects of ambient pollutants are clearer on respiratory than on 
cardiovascular health, and among children and the elderly than among adults, in Helsinki. 
Although some differences were observed in the health effects of different particle size 
fractions and PM2.5 from different sources, they all appear capable of causing adverse 
health effects. These results underline the importance of particulate matter together with 
ozone as a main environmental threat to health also in Helsinki.
Keywords; air pollution, cardiovascular, emergency room visit, epidemiology, hospital 
admission, mortality, respiratory, particulate matter, particulate number 
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TIIVISTELMÄ
Ilmansaasteet ovat yksi haitallisimmista ympäristöaltisteista ihmisten terveydelle. 
Hiukkasmaisia ja kaasumaisia ilmansaasteita on tutkittu viimeisten vuosikymmenien 
aikana, ja useissa tutkimuksissa pienhiukkaset (läpimitta < 2.5 µm, PM2.5) ja hengitettävät 
hiukkaset (< 10 µm, PM10) on yhdistetty lisääntyneeseen sairastuvuuteen ja kuolleisuuteen. 
Hiukkasten koko ja koostumus vaikuttavat mahdollisesti niiden haitallisuuteen. Hiukkasten 
koostumus vaihtelee, koska niitä syntyy erilaisissa prosesseissa. Erilaisten hiukkasten 
terveyshaittoja on kuitenkin harvoin vertailtu, sillä niiden mittausaineistoa on ollut vähän 
saatavilla.
Tämän väitöskirjatutkimuksen tarkoituksena oli selvittää onko lyhytaikaisella 
altistumisella ilmansaasteille vaikutusta ihmisten terveyteen. Hiukkasia eri kokoluokissa, 
otsonia (O3), typpidioksidia (NO2), häkää (CO), sekä pienhiukkasia (PM2.5) eri lähteistä 
tutkittiin erillisissä analyyseissä. Terveysvasteista tutkittiin kuolleisuutta ja sairastuvuutta 
sydän- ja verisuonitauteihin sekä hengityselinsairauksiin. Jotta eroja ikäryhmien välisessä 
herkkyydessä pystyttiin vertailemaan, analyysit suoritettiin erikseen kolmelle eri ikä-
ryhmälle. Ikäryhminä analyyseissä käytettiin lapsia alle 15-vuotiaat, aikuisia 15–64-
vuotiaat ja vanhuksia yli 65-vuotiaat.
Koko aineisto tutkimukseen oli kerätty vuosina 1998–2004 pääkaupunkiseudulta, 
joka kattaa Helsingin, Vantaan, Kauniaisen ja Espoon kaupungit. Hiukkasten massan 
ja lukumäärän sekä typpidioksidin ja hään mittaukset suoritettiin keskusasemilla. 
Otsonipitoisuuksia puolestaan mitattiin kaupunkitausta-asemalla. Pienhiukkasmassasta, 
PM2.5, erotettiin neljä lähdettä: liikenne, kaukokulkeuma, maaperä sekä öljyn/hiilen 
poltto. Päivittäiset lukumäärät kuolleisuudesta, sairaalanotoista ja poliklinikkakäynneistä 
saatiin kansallisista rekistereistä.
Vuosikeskiarvopitoisuus (keskihajonta) PM2.5 hiukkasille Helsingissä oli 9 (5.8) µg/m
3. 
Yli puolet pienhiukkasmassasta oli kaukokulkeutunutta ja viidennes oli peräisin paikallisesta 
liikenteestä. Loppu osuus hiukkasmassasta oli maaperästä, öljyn/hiilen poltosta sekä muista 
tässä tutkimuksessa tunnistamattomista lähteistä. Keskiarvopitoisuudet (keskihajonta) 
ultrapienille hiukkaselle (UFP, < 0.1 µm) ja akkumulaatio moodin hiukkasille (0.1–
0.3 µm) olivat 8 203 (5 137) ja 359 (261) 1/cm3. Keskiarvopitoisuudet (keskihajonta) 
muille saasteille olivat; karkeat hiukkaset (PM2.5–10, 2.5–10 µm) 9.9 (8.3) µg/m
3, NO2 28 
(11.3) µg/m3, CO 0.5 (0.2) mg/m3, ja O3 71 (20) µg/m
3.
Tutkimuksessa havaittiin vahva yhteys lasten astman pahenemisen ja liikenneperäisten 
saasteiden (ultrapienet hiukkaset, NO2, CO) sekä otsonin pitoisuuksien kohoamisen välillä. 
Yli 65-vuotiaiden joukossa akkumulaatio moodin ja PM2.5 hiukkasten, mutta myös karkeiden 
hiukkasten pitoisuuksien noustessa kaikkien hengityselinsairauksien, keuhkokuumeen, 
sekä astman ja kroonisen keuhkoahtaumataudin (COPD) todettiin lisääntyvän. Lapsilla 
liikenneperäisten saasteiden haittavaikutus ilmeni 3–5 päivää altistumisen jälkeen, mutta 
yli 65-vuotiailla vaikutukset olivat nopeampia. Astma ja krooninen keuhkoahtaumatauti 
pahenivat yli 65-vuotialla myös otsonipitoisuuksien noustessa kesällä. Aikuisilla havaittiin 
vähän yhteyksiä terveyden ja ilmansaasteiden välillä.
Sydänsairauksien ja ilmansaasteiden välillä havaittiin vähän yhteyksiä. Kokonais-
sydäntauti- ja aivohalvauskuolleisuus olivat yhteydessä PM2.5 pitoisuuksiin lämpimänä 
kautena, mutta samaa yhteyttä ei havaittu sairastuvuudessa aivohalvauksiin. Sydämen 
rytmihäiriöiden ja pienhiukkasten välillä havaittiin myös heikko yhteys. 
Tämä väitöstutkimus osoittaa, että ulkoilman hiukkaset ja otsoni aiheuttavat 
lisääntynyttä hengityselinsairastavuutta ja -kuolleisuutta myös pääkaupunkiseudulla. 
Vaikka sydänsairauksien ja ilmansaasteiden välillä havaittiin tässä tutkimuksessa vähän 
yhteyksiä, aikaisempien kansainvälisten tutkimusten ja suomalaisten paneelitutkimusten 
tulokset osoittavat, että hiukkasilla on merkitystä erityisesti hengityselinsairaiden 
sekä sydäntautipotilaiden joukossa. Akkumulaatio moodin sekä PM2.5 hiukkaset ovat 
useammin yhteydessä hengityselinsairauksiin kuin hiukkaset muissa kokoluokissa. Tämä 
voi osittain johtua paremmasta altistuksen arvioinnista näille hiukkasille verrattuna 
ultrapieniin ja karkeisiin hiukkasiin. Liikenneperäiset ja kaukokulkeutuneet PM2.5 
hiukkaset aiheuttavat eniten terveyshaittoja, mutta myös maaperän hiukkaset ovat 
haitallisia. Ultrapienet hiukkaset ja NO2 ovat liikennepäästöjen indikaattoreita, mutta tässä 
tutkimuksessa ei voitu erottaa yksittäistä liikennepäästöjen komponenttia, joka aiheuttaa 
havaitut terveysvaikutukset lapsilla. Aikuisväestö näyttää kaiken kaikkiaan olevan 
vastustuskykyisempää ilmansaasteiden vaikutuksille kuin lapset ja yli 65-vuotiaat. 
Yhteenvetona voi todeta, että ulkoilman hiukkasten ja otsonin vaikutukset ovat 
voimakkaammat hengitys- kuin sydän- ja verenkiertoelimistöön sekä lapsilla ja yli 65-
vuotiaila verrattuna aikuisväestöön Helsingissä. Vaikka eroja hiukkasten kokoluokkien 
ja lähteiden välillä havaittiin, niillä kaikilla näyttää olevan haitallisia terveysvaikutuksia. 
Tämän tutkimuksen tulokset osoittavat, että ulkoilman hiukkaset ja otsoni ovat merkittäviä 
ympäristöterveydellisiä uhkia myös Helsingissä.
Avainsanat; epidemiologia, pienhiukkaset, hiukkasten lukumäärä, hengityselinsairaus, 
ilmansaasteet, kuolleisuus, poliklinikkakäynti, sairaalanotto, sydänsairaus 
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1 IntRoDUCtIon
The harmful health effects of air pollutants were first described as early as in the 1930’s 
after a fog episode in the Meuse valley, Belgium (Nemery et al., 2001). Increased mortality 
and morbidity counts were also reported after a fog episode in Donora, Pennsylvania in 
1947 (Schrenk, 1949). However, it has often been referred that it was not until the famous 
London fog episode in December 1952 that truly awakened people for the hazardous effects 
of air pollutants. Increase in the short-term mortality in London after the fog episode 
was striking as had been the concentrations of ambient pollutants, and the link between 
pollution and mortality seemed obvious (Ministry of Health, 1954). Thereafter the pollutant 
levels decreased towards the late 1970’s as a result of successful regulation actions. At that 
point, several investigators already concluded that there was enough evidence that low to 
moderate particulate pollutant levels did not affect human health (Holland et al., 1979). 
However, there were also other scientists who believed that even low particulate matter 
levels could have harmful effects on health (Pope and Dockery, 2006). More than a decade 
later their view was highlighted again when several unconnected epidemiological research 
groups found associations between rather low levels of particulate matter and mortality for 
cardiorespiratory diseases (Dockery et al., 1993; Pope et al., 1992; Schwartz and Marcus, 
1990). 
Today, the effects and risks of particulate matter and other air pollutants are still under 
vigorous examination. Recently, considerable effort was put into determining the risks of 
air pollutants in the Clean Air for Europe (CAFÉ) Programme (European Union, 2005). 
The CAFÉ Programme estimated that 1,300 premature deaths occur annually in Finland 
due to air pollutants. That is, in a country where the levels of pollutants are generally 
low. For Europe in total, the estimate was over 370,000 premature annual deaths because 
of air pollution. While mortality is the most severe outcome of the health effects of air 
pollutants, much larger population groups are suffering from milder effects that lead to 
reduced quality of life, increased morbidity counts, and higher costs of health care.
The air pollution research has continued for several decades already, but there still 
remains uncertainty about what are the most harmful ambient air pollutants, and where are 
they emitted from (WHO, 2007). One reason for the uncertainty is that the composition 
of ambient particles has changed over time because of changes in industrial development 
(Seinfeld and Pandis, 2006). Developed measurement devices have made it possible 
to investigate particles in different size fractions. The first particulate measures and air 
pollutants used in epidemiological studies were sulfur dioxide (SO2), total suspended 
particles (TSP), black smoke, and inhalable particles (PM10, diameter < 10 µm), whereas 
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coarse (PM10–PM2.5, 2.5–10 µm), fine (PM2.5 < 2.5 µm), and ultrafine (< 0.1 µm) particles 
are nowadays the focus of research (Delfino et al., 2005; Donaldson and Stone, 2003; 
Hoek et al., 2000; Laden et al., 2000; Mar et al., 2000). Fine particles, PM2.5, have already 
become the target of current air pollution regulations with a view to protect human 
health. However, toxicological studies suggest that ultrafine particles could be the most 
detrimental for health (Delfino et al., 2005; Donaldson and Stone, 2003; Valavanidis et al., 
2008). Of the gaseous pollutants, NO2 and CO have often been considered as markers of 
traffic-related pollutants, and not having independent health effects at the current levels, 
whereas the harmful effects of O3 are biologically plausible (Bates, 2005; Brown et al., 
2007; Gryparis et al., 2004; Hester and Harrison, 1998; Schwela, 2000).
Efforts to determine the health effects of ultrafine particles, have been made in Finland 
as part of the multi-city studies ULTRA (Exposure and Risk Assessment for Fine and 
Ultrafine Particles in Ambient air Project) (Pekkanen et al., 2000), HEAPSS (The Health 
Effects of Particles on Susceptible Subpopulations Project) (Lanki et al., 2006a; von Klot 
et al., 2005), and AIRGENE (Air Pollution and Inflammatory Response in Myocardial 
Infarction Survivors: Gene-Environment Interaction in a High Risk Group) (Peters et al., 
2007; Ruckerl et al., 2007a) and also elsewhere (Andersen et al., 2008; Andersen et al., 
2007a; Peel et al., 2005; Wichmann et al., 2000). There has also been a few chamber 
studies where healthy people have been exposed to particulate pollutants in controlled 
conditions (Samet et al., 2007). However, there has been a lack of long and good quality 
measurement data of particles in the ultrafine size fraction for epidemiological time-
series or cohort studies (Englert, 2004). Fine particles have been more often measured 
and studied, and the main sources of fine particles are known. Fossil fuel combustion e.g. 
emissions from traffic and power plants, re-suspended dust from soil, wood and biomass 
combustion, as well as sea salt spray in areas close to sea shore are all sources for fine 
particulate matter (Seinfeld and Pandis, 2006). During the last decade, the health effects 
of source-specified particles have also been studied (Andersen et al., 2007b; Laden et al., 
2000; Lanki et al., 2006b).
In Helsinki, the measurements for the size fractioned particles started already in the 
mid 1990’s (Hussein et al., 2004b) when the new era of air pollution research had just 
begun. Together with regular air pollutant monitoring data this particulate measurement 
data enabled the examination of the short-term health effects of ambient particles in several 
different size fractions, and the effects of gaseous pollutants. Source apportionment for the 
fine particle mass, on the other hand, enabled the investigation of the health effects of fine 
particles, PM2.5, from different sources. Thus this population level study is among the 
first that was able to use long-term continuous measurement data of the size-fractioned 
particles and mass of source apportioned PM2.5, and also to link it to the excellent Finnish 
registers on health. 
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2 ReVIeW oF tHe LIteRAtURe
2.1 Air pollution
Air pollution can be defined as a condition in which the concentrations of substances in 
the atmosphere are high enough to cause measurable effect on man, animals, vegetation or 
materials. A “substance” here is any natural or anthropological airborne chemical element or 
compound that can exist in the atmosphere as gases, liquid drops or solid particles (Seinfeld, 
1986). The most considerable sources of anthropogenic air pollutants are processes 
involving fossil fuel combustion such as energy production, traffic, and industry.
2.1.1 Size fractions and sources of particulate matter
When speaking of “particulate matter” we refer to substances that under normal conditions 
are in liquid or solid form in the atmosphere and that vary in size and density (Seinfeld, 
1986). Particles under 20 µm in aerodynamic diameter are of special interest because they 
settle out slowly from the air (Koutrakis and Sioutas, 1996). Because the exact size of 
particles cannot be determined, they are usually considered as spheres and the measure 
“aerodynamic diameter” is used to describe the size of particles. Strictly speaking, 
aerodynamic diameter is the diameter of a sphere of unit density (1g cm-3) that has the 
same gravitational settling velocity as the particle in question. Particulate matter is often 
classified particularly by the physical size of particles. Physical size refers to the above 
mentioned aerodynamic diameter of particles that varies from few nanometers to tens 
of micrometers. Many properties and atmospheric reactions of particles are predicted 
based on their size, the compounds they are formed of, and the size of their surface area 
(Seinfeld, 1986). 
Ultrafine particles have diameter less than 0.1 µm. One sub-fraction of ultrafine 
particles is called nucleation mode (< 0.01 µm). These particles are formed by gas-to-
particle conversion, and condensation of hot vapors, but sometimes they are also directly 
emitted as particles from combustion processes. Nucleation mode particles have a short 
life span and they coagulate fast with each other to form larger particles, Aitken mode 
particles (0.01–0.1 µm) (Seinfeld and Pandis, 2006). In addition to formation via gas-to 
particle conversion, condensation and coagulation processes, ultrafine particles are also 
emitted directly as particles.
Ultrafine particles are derived from local emission sources such as traffic and fuel 
combustion in stationary sources (Colls J, 2002; Seinfeld and Pandis, 2006). Ultrafine 
particles contribute little to the particulate mass (Pekkanen and Kulmala, 2004), but they 
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are large in number and have high short-term peak concentrations. Therefore especially 
nucleation mode particles can make a considerable contribution to the short-term inhalable 
particle exposure. Aitken mode particles have lower peak concentrations than nucleation 
mode, but they are always present in the ambient air (Colls J, 2002; Seinfeld and Pandis, 
2006). Besides having large number, ultrafine particles have also large surface area in 
relation to their mass. From the epidemiological point of view, large surface area means 
that there is more active area for particle-cell interactions in the airways, which is one 
reason why ultrafine particles are considered more toxic than larger particles (Donaldson 
and Stone, 2003; Sioutas et al., 2005). Another reason for the harmfulness of these 
particles can be their ability to penetrate deep into the airways. It has been demonstrated 
that particles in the size fraction of < 0.1 µm would reach best the alveolar region of the 
lungs (Schulz, 2000). 
Fine particles (PM2.5, < 2.5 µm) are emitted straight from combustion sources but they 
are also formed in the air via condensation of precursor gases onto existing particles, and 
via coagulation of ultrafine particles (Seinfeld and Pandis, 2006). The growth rate depends 
on the number of particles, their velocity, and surface area. The term “fine particles” is 
currently considered a synonym for the mass of particles less than 2.5 µm in aerodynamic 
diameter, PM2.5. Slightly stricter size range, 0.1 µm to ~ 2 µm, defines a sub-fraction of 
fine particles that is also called accumulation mode (Seinfeld and Pandis, 2006). Fine 
and accumulation mode particles do not grow into larger, coarse, particles due to growth-
limiting physical factors and therefore they are “accumulating” and lasting (Seinfeld and 
Pandis, 2006). Particles in the accumulation mode fraction are special in that they account 
for most of the ambient fine particle surface area (Hussein et al., 2004b; Seinfeld and 
Pandis, 2006). 
Fine particles consist mainly of sulfate, nitrate, ammonium and secondary organics 
(Seinfeld and Pandis, 2006). Most of the particles are emitted from combustion processes 
using fossil fuel such as traffic and power plants. Other fine particle sources are waste 
incinerators, wood combustion, especially in residential areas where wood may be used as 
a secondary source of energy, and sea salt spray in the vicinity of sea (Colls J, 2002). Fine 
particles have low settling velocity that enables long life span and transportation of these 
particles over thousands of kilometers from the emission source (Spengler and Wilson, 
1996). Therefore the total ambient particle mass is always affected by elsewhere produced 
fine particles as well as older particles. The composition of fresh and old particles may be 
different because of the conversion of particles through chemical processes that take place 
in the atmosphere (Seinfeld, 1986; Seinfeld and Pandis, 2006). Local combustion particles 
and long-range transported particles are therefore also defined as primary and secondary 
particles, respectively, and thought to probably have different health effects (Schwarze et 
al., 2006).
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Generally, particles from 2.5 up to 50 µm are considered as coarse particles and 
they are mostly primary particles containing only some secondary sulfates and nitrates 
(Seinfeld and Pandis, 2006). In epidemiological studies, however, the diameter used for 
coarse particles is most often defined as 2.5–10 µm (PM10–PM2.5), because these particles 
are in inhalable size fraction, and may therefore have biologically plausible effects on 
health. These particles are formed by fragmentation of matter and in other mechanical 
processes such as wearing off roads (Colls J, 2002). Traction sanding gives also rise for 
the formation of coarse particles that are thereafter distributed by local winds. However, 
these particles are not transported far from their initial source because they are larger in 
size and heavier than combustion derived particles and therefore deposited faster. Both, 
the coarse and the fine fraction of particles contain also material of biological origin like 
bacteria, pollen, and fungal spores. However, the major part of such intact bio-aerosols 
occurs in the coarse mode, and in deposited and re-suspended dust, particles of biological 
origin may be abundant (Monn, 2001).
2.1.2 Ozone and other gaseous air pollutants
Ozone (O3) is a known irritant gas in the troposphere. Ozone is a reactive, light blue and 
piercing smelling gas that is formed as a secondary pollutant in conditions where nitrogen 
oxides, volatile organic compounds (VOCs), and sunlight are present (Bernstein et al., 
2004; U.S.EPA, 2006). In the rural areas, ozone formation occurs also with the help of 
methane that derives from rice fields, domestic animals, and dumping grounds. Simplified 
equations that regulate the ozone concentrations are as follows. First, nitrogen dioxide is 
dissociated into nitric oxide and atomic oxygen with the help of sunlight: 
O2 + hυ → NO + O
Where in hυ h is Planck’s constant and υ is the frequency of light. Atomic oxygen then 
combines with molecular oxygen to form ozone: 
O + O2 → O3
If the photostationary cycle described above is altered by events consuming nitric oxide or 
favoring the production of nitrogen dioxide, the formation of photochemical pollution takes 
place. The cycle is most often altered by reactions between nitric oxide and atmospheric 
peroxides (RO2) that lead to the formation of nitrogen oxide:
NO +RO2 → NO2 + RO
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It is here when VOCs are involved with the ozone production, because atmospheric 
peroxides are formed in the oxidation processes of VOCs. In addition, tropospheric ozone 
concentrations are slightly affected also by the air streams from the stratosphere (Jacob, 
2000). Destruction of ozone during daytime can occur by process involving sunlight:
O3 + hυ → O + O2
O3 + O → 2 O2 
or more often during the night by catalytic reactions involv ing e.g. NO:
NO + O3 → NO2 + O2
NO2 + O → NO + O2   
Even though ozone in the troposphere is an oxidative air pollutant, we must not forget 
that this gas in the stratosphere has a vital function in inhibiting ultraviolet radiation from 
reaching the surface of the Earth.
Nitrogen dioxide (NO2) is formed mostly in combustion processes of mobile sources 
involving nitrogen from air and from fuels (Vovelle, 2000). Nitrogen dioxide is also 
piercing smelling gas, whose color at high concentrations is reddish brown. Nitrogen 
oxides (NOx), including NO2 and nitrogen monoxide (NO), are primary pollutants and 
they perform as precursor pollutants for particulate matter and ozone. 
Carbon monoxide (CO) is an odorless and tasteless gas that is derived from incomplete 
burning of carbon-containing compounds. Carbon monoxide is formed instead of carbon 
dioxide when there is insufficient amount of oxygen available for the combustion process 
(Vovelle, 2000). Natural sources of CO are volcanic eruptions and bush and forest fires. 
Sulfur dioxide (SO2) is a by-product of burning of sulfur containing fuels. Sulfur 
content differs between fuels, coal and diesel having higher sulfur content than gasoline 
(Vovelle, 2000). Prior to the advancing of particulate matter measurements, SO2 was often 
used as The air pollution measure in epidemiological health studies. However, as a result 
of SO2 restrictions, the combustion processes have thereafter developed and the levels of 
SO2 have declined to levels with minor health effects.
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2.2 Health effects of ambient air pollution
2.2.1  General health effects of ambient air pollutants 
The health effects of air pollutants were first observed after the massive smog episodes in 
the Meuse valley, Belgium in 1930, and in London in 1952. The described health effects 
considered associations between sulfur dioxide and cardiopulmonary health (Ministry of 
Health, 1954; Nemery et al., 2001). By the late 1970’s the levels of air pollutants had 
remarkably decreased as a result of successful emission control efforts, and the common 
opinion was that no health effects at the prevailing levels would occur (Brunekreef 
and Holgate, 2002). However, in the early 1990’s when two large cohort studies from 
North America revealed associations between mortality and air pollutants at moderately 
low levels (Dockery et al., 1993; Pope et al., 1995), a new era of air pollution research 
commenced.
In numerous researches, associations for short-term and long-term exposure to 
particulate pollutants with various health outcomes have been observed. (Brunekreef 
and Holgate, 2002; Pope and Dockery, 2006). The acute effects have been studied by 
determining the effects of daily variation in air pollutant levels on daily morbidity or 
mortality counts. Morbidity, studied as increased hospital admission and emergency room 
visit counts, and as less severe outcomes like respiratory symptoms, and changes in vascular 
system, has been associated with exposure to air pollutants at short term (Brunekreef and 
Holgate, 2002; Delfino et al., 2005; Koenig, 1999). Short-term exposure to air pollutants 
has also shown to increase mortality (Mar et al., 2000; Samoli et al., 2008; Wichmann et 
al., 2000). Short-term studies, especially panel studies, have also been used to study the 
effect mechanisms of pollutants. In these studies outcomes such as inflammation markers 
and electrocardiography parameters have been studied (Gold et al., 2000; Ruckerl et al., 
2007a). The effects of long-term exposure have been studied in cohort studies, where 
increased cancer mortality among other outcomes has also been linked to ambient air 
pollutants (Brunekreef, 2007; Chen et al., 2008; Dockery et al., 1993).
Some population groups have also been found to be more sensitive to the effects of 
ambient air pollution than others. Children and the elderly, people with cardiopulmonary 
diseases such as acute respiratory infections, congestive and ischemic heart disease, 
defects in the electrical control of the heart, hypertension, influenza, COPD, or asthma 
have shown to be particularly vulnerable to the effects of pollutants (Annesi-Maesano et 
al., 2003; Bateson and Schwartz, 2004; Berglind et al., 2008; Peel et al., 2007; Pope, 2000; 
Wellenius et al., 2005; Zanobetti et al., 2000). There are also suggestions that diabetics 
suffer from milder exposures to ambient pollutants than healthy individuals (Gold, 2008; 
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Goldberg et al., 2001c; Peel et al., 2007; Zanobetti and Schwartz, 2001). However, no 
matter how low the exposure to pollutants is, a threshold level under which harmful health 
effects would not occur has not been found (Schwartz et al., 2002).
The levels of the severity of the health effects, and proportion of population affected 
on each level is illustrated in Figure 1. It can be seen at the bottom of the pyramid that the 
population affected by less severe outcomes is much larger than population that suffers 
from the more severe outcomes such as mortality or hospitalization. This suggests that the 
effects observed in mortality studies are only the tip of the iceberg when considering the 
entity of health effects caused by air pollution (WHO, 2005).
The health effects of long-term and short-term exposure to air pollutants have been 
studied in cohort and time-series, which form the basis for the regulations of air pollutant 
levels (Bell et al., 2004b; U.S.EPA, 2006; WHO, 2005). Cohort studies are longitudinal 
studies used for estimating the effects of chronic exposure to pollutants, covering also 
partly the short-term effects. Ability to cover both long- and short-term exposure is the 
main strength of cohort studies. Time-series studies, on the other hand, estimate only the 
effects of short-term changes (usually daily) in air pollution on the short-term (daily) 
changes in a health outcome. Advantage of cohort and time-series studies is the large 
number of cases, which increases the power of the analyses, and also gives possibility to 
study rare diseases. Time-series studies have also low costs, because data collection from 
registers and air pollution monitoring are inexpensive. However, results from time-series 
studies are sometimes thought to underestimate the total effect size, which relates to the 
absence of estimation of long-term effects. This means that air pollution can increase the 
risk of chronic diseases leading to frailty but is unrelated to timing of death (Kunzli et 
al., 2001; Ren and Tong, 2008). Short-term studies have sometimes been criticized also 
because the findings are thought to be a result of “harvesting effect”. This means that 
deaths or hospitalizations would increase among those persons who are the sickest and 
would have died or become hospitalized in few days anyhow (Rothman, 2002). It seems, 
however, that harvesting does not explain the observed acute effects (Schwartz, 2001), 
and therefore also results from time-series studies are valid to be used in the regulation 
processes.  
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Figure 1.  Pyramid of health effects associated with air pollution.
2.2.2 Possible mechanisms of ambient air pollutants on cardiorespiratory health
To better understand and avoid the harmful effects of air pollutants, the mechanisms of the 
health effects have been under vigorous investigation. For fine and ultrafine particles, the 
suggestive effect mechanisms are presented in Figure 2. 
Particulate matter deposited in the airways can cause epithelial barrier disruption via 
oxidative and toxic compounds imported on their surface (Costa and Dreher, 1997; Gilmour 
et al., 1996; Vinzents et al., 2005). Structural changes in the mucosal membranes and 
disruption of the epithelial barrier caused by irritation can lead to pulmonary dysfunctions 
and increase the permeability of airway epithelia (Timonen et al., 2004). Increased 
permeability facilitates further the penetration of macromolecules and particulate matter 
into the epithelium tissue and circulation (Bhalla, 1999; Chuang et al., 2007).
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Figure 2.  Hypothetical mechanisms by which ambient fine and ultrafine particles end in morbidity and 
mortality.
Inflammation, a mechanism that lies behind several pulmonary and extra-pulmonary 
diseases, can be induced by the oxidative stress following particulate exposure (Brook 
et al., 2004; Delfino et al., 2005; Rahman and MacNee, 1998) (Figure 2). In pulmonary 
inflammation, cytokines such as interleukins 1 and 2 are released that further activate 
the defense mechanisms in the airways. Local inflammation may also lead to systemic 
inflammation where inflammation markers such as fibrinogen and C-reactive protein are 
released into the blood circulation. (Gabay and Kushner, 1999). Systemic inflammation 
in the airways leads to deterioration of lung function (Thyagarajan et al., 2006), and it 
possibly increases the risk of chronic pulmonary disease, cardiovascular disease and 
several neurological and skeletal defects (Agusti, 2005). The cardiovascular effects of 
particles may also occur through local inflammation in the blood vessels. Inflammation 
can induce the formation of plaques that may rupture as a result of sudden increase in 
blood pressure, for example. This can cause thrombus in the heart or brain vessels, which 
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are observed as myocardial infarction or ischemic stroke, respectively. Inflammation may 
also increase the levels of interleukin 6 that promotes blood clotting, which also increases 
the risk of cardiac arrest and stroke (Samet et al., 2007).
The effect of fine particles on cardiovascular system has also been suggested to occur 
via mechanisms including the autonomic nervous system. In the respiratory system 
several sensory receptors become activated by chemical components on inhaled particles, 
through oxidative stress, or through inflammation. This induces reflex changes in the 
cardiovascular system (Widdicombe and Lee, 2001). The autonomic nervous system 
controls heart rate variability (HRV) that thus can be affected by short-term exposure 
to air pollutants (Chuang et al., 2007; Gold et al., 2000; Lipsett et al., 2006; Timonen et 
al., 2006; Yeatts et al., 2007). Changes in HRV further increase the risk of myocardial 
ischemia and the risk of arrhythmias especially among susceptible persons (Berger et al., 
2006; Rich et al., 2005). In addition, the autonomic nervous system, the current state of the 
myocardium, and myocardial vulnerability are contributing to the cardiac morbidity and 
mortality as presented by Zareba et al. (2001).
The effect mechanisms of ultrafine particles are partly the same as those of fine 
particles. However, it has been shown that ultrafine particles cause more oxidative stress 
than larger particles (Li et al., 2003). Reason for the greater oxidative capacity maybe the 
small size or large number of particles, because ultrafine particles composed also of non-
toxic substances have been found to be harmful (Donaldson and Stone, 2003; Monteiller 
et al., 2007; Nel et al., 2006). Carbon black particles and aggregates of ultrafine particles 
can also impair the phagocytosis of human macrophage cell line to a greater extent than 
fine particles, which is why inflammation possibly occurs more readily after exposure 
to ultrafine particles compared to fine particles (Donaldson et al., 2001; Lundborg et al., 
2006; Renwick et al., 2001). However, opposite results have also been found, showing 
higher inflammation marker occurrence after exposure to fine or coarse particles than 
ultrafine particles (Becker et al., 2005). 
Another effect mechanism of ultrafine particles is suggested to be the translocation 
of particles into the circulation and further into secondary target organs (Nemmar et al., 
2002; Nemmar et al., 2004; Oberdorster et al., 2005). However, it has been reported that 
only 5% of the deposited particles in the lungs is systemically translocated (Kreyling et 
al., 2006). Thus it can be that the effects of the smallest particles are due to their larger 
surface area that determines the potential number of reactive groups on particle surfaces, 
rather than the small size alone. Among the reactive groups on ultrafine particle surfaces 
are metals. Evidence of the toxicity of particle coating metals has been found in cell and 
animal studies, where iron, silicon, zinc, copper, manganese, nickel, and vanadium have 
been associated with increases in various inflammation markers (Becker et al., 2005; de 
Kok et al., 2006; Molinelli et al., 2006; Rice et al., 2001).
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Health effects of coarse particles may also occur via the inflammatory cascade (Schins 
et al., 2004). Especially, the endotoxin contaminants of particles have been linked to the 
harmfulness of coarse particles (Becker et al., 2003; Huang et al., 2002; Schins et al., 
2004). Besides endotoxins, the insoluble components of coarse particles can modulate the 
functionality of alveolar macrophages (Soukup and Becker, 2001). Coarse particles have 
also been found to activate monocytic cells, which may enhance responses to allergens 
or bacteria in individuals with allergy (Alexis et al., 2006). However, relatively little 
knowledge is available on the exact mechanisms of health effects of coarse particles.
Causality of the health effects of gaseous pollutants ozone and nitrogen dioxide derives 
from the oxidative capacity of these gases. However, direct contact between gases and 
pulmonary epithelial is unlikely, because O3 and NO2 react readily with substrates in the 
lung lining fluid (Kelly and Tetley, 1997). Therefore, the deleterious effects are actually 
caused by the oxidized species that arise from these interactions, and that further can 
initiate inflammation (Kelly, 2003). The reactions of NO2 and O3 in the airways can also 
lead to increased sensitivity for allergic responses to allergens such as pollens. 
The postulated mechanism through which CO could cause health effects differs from 
O3 and NO2. Carbon monoxide is not oxidative, but it can bind into cardiac myoglobin 
that normally delivers oxygen to the heart muscle (McGrath, 2000). Thus massive 
exposure to CO may lead to hypoxia, which increases the risk of cardiac events especially 
among people with heart disease. However, as the ambient levels of CO are rather low, it 
may be that only the vulnerable individuals suffer from the health effects of CO, and the 
mechanism for these effects are not completely determined (Hester and Harrison, 1998). 
2.3  Epidemiological evidence of the short-term health 
effects of ambient air pollution in time-series studies
2.3.1 Methodology of time-series studies
In environmental epidemiology, longitudinal study designs such as time-series studies 
are often used for the study of the acute health effects (Ren and Tong, 2008). In time-
series studies, the associations between daily changes in air pollution levels and daily 
variation in a health outcome are determined (Goldberg et al., 2008). The health effects 
are estimated by using regression models where the concentration of air pollutant is 
included in the model lagged from 0 (current day) to several days. Because the health 
effects are investigated within the same geographical area, the population serves as its own 
control, and the confounding by population characteristics (occupation, socioeconomic 
status, smoking) is minor (Bell et al., 2004b). The same is true for other variables that are 
independent of time. However, some possible confounding factors, like weather, and time 
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dependent variables (weekday) that vary on day-to-day level must be considered in the 
regression models of time-series studies (Bell et al., 2004b).
The health data for time-series studies is often derived from health registers maintained 
by hospitals or other national institutions. This data usually includes cause-specific daily 
death, hospital admission, or emergency room visit counts by diagnoses for the population 
of the determined study area. 
2.3.1.1 Air pollution measurements and possible measurement errors in time-series 
studies
Air pollution measurements for time-series studies are performed at one or several central 
measurement sites. Often the mass and number count concentrations are obtained from 
regular air quality monitoring networks. These pollutant levels are thought to be a proxy 
for average personal exposure, which, however, is not always the case. A problem with 
these measurements is that exposure assessment for the population in the study area varies, 
and also the exposure assessment for different particulate size fractions may vary. In the 
case of exposure within the population, bias may occur if the activity of an individual 
is correlated with the pollutant concentrations measured at central sites (Pekkanen and 
Kulmala, 2004). This is an example of so called Berkson error, which is suggested to cause 
little bias in epidemiological air pollution studies (Zeger et al., 2000). This is because error 
occurs only in the case when people respond to the possible weather and air pollution 
warnings by changing their daily activities e.g. by reducing exercise or by opening or 
closing their windows. Particles in different size fractions, for one, have different source 
locations and the behavior and aerodynamic properties of particles differ by size (Kulmala 
et al., 2004). This leads to local variations in the exposure to different particulate fractions. 
Additionally, if particles produced from indoor sources have similar compositions than 
ambient particles, they may be also a cause for exposure misclassification (Zeger et al., 
2000). 
Earlier studies have shown that central site measurements of fine particles are valid 
enough to be used in epidemiological time-series studies (Hoek et al., 2008; Monn, 2001; 
Pekkanen and Kulmala, 2004; Tsai et al., 2000b). This is partly due to the even distribution 
of fine particles, and accumulation mode particles, over large areas because of their low 
deposition rate (Seinfeld and Pandis, 2006). 
Unfortunately, central site monitoring values of ultrafine particle counts and coarse 
particulate mass are probably less valid proxies to be used for the personal exposure 
assessment than measurements of fine particles (Pekkanen and Kulmala, 2004). There are 
two main reasons for this. One is that the spatial variation in the ultrafine particle counts and 
coarse particle mass can be great. Ultrafine particles are rapidly diluted and condensed into 
larger particles when emitted, and therefore the concentration diminishes rather fast as the 
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distance from the source increases (Zhu et al., 2002a; Zhu et al., 2002b). Coarse particles, 
on the other hand, are often stirred up by wind and thereafter rapidly deposited because 
of their larger mass, which also leads to differences in spatial distribution. Another reason 
for the difficulties in accurate exposure assessment is the poor penetration of ultrafine and 
coarse particles through the wall and window structures of buildings (Long et al., 2001; 
Schulz, 2000). This derives from the high Brownian motion of ultrafine particles, and the 
greater size of coarse particles. However, in a recent study the correlations between night-
time ultrafine number counts indoors and at central site seemed to correlate fairly well 
(Hoek et al., 2008). This implies that indoor sources such as cooking partly explain why 
the 24-hour correlations between indoor and outdoor ultrafine particle measurements are 
low. Indoor sources may also have a greater impact on the personal exposure to particles 
during winter time when infiltration of particles is lower than during summer (Brown et 
al., 2008).
In addition to the air-tightness of buildings, the amount and quality of air filtration 
has great effect on the indoor concentrations of outdoor particles (Hanninen et al., 2005) 
affecting also personal exposure. Air filtration has been shown to decrease the indoor 
levels of ultrafine particles more efficiently than the levels of accumulation mode particles 
(Hussein et al., 2004a; Koponen, 2001). However, the filtration efficiency is dependent 
on the filter type in use. In addition, air exchange rate affects the indoor levels of outdoor 
particulates, indoor concentrations following the changes in outdoor levels more accurately 
when air exchange rates are high (Guo et al., 2008). Because the indoor sources affect the 
indoor concentrations and personal exposure, recent studies have suggested that particles 
from ambient and non-ambient origin should be separated when studying the personal 
exposure and health effects of particulate matter (Ebelt et al., 2005; Wallace and Williams, 
2005).
Exposure assessment for gaseous pollutants O3, NO2, and CO has rarely been 
validated in time-series studies. Air filters attached to mechanical ventilation can remove 
approximately 10% of the outdoor originated O3 (Hyttinen et al., 2006; Hyttinen et al., 
2003), and the half life of ozone indoors is short, probably less than 20 minutes (Jakobi 
and Fabian, 1997). However, there is little information about what the actual infiltration 
rate of O3 is, how fast it reacts with indoor surfaces, and what is the role of by-products 
formed in the reactions between ozone and surfaces or other gases (Weschler, 2000). 
These by-products may include irritating substances such as formaldehyde and some 
carboxylic acids. Secondary organic aerosols also result from ozone reactions. Thus some 
of the respiratory health effects of ozone could be due to the exposure to these by-products 
indoors (Weschler, 2004).
Nitrogen dioxide, CO, and also ultrafine particles are mainly emitted from vehicles, 
which is why the levels of these three pollutants are highly correlated. Therefore many 
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studies have suggested that NO2 and CO would be more of surrogates of the exposure 
to the mixture of traffic-related pollutants, than causal pollutants themselves (Cyrys et 
al., 2003; Fusco et al., 2001; Ruckerl et al., 2006). The spatial variation in NO2 levels 
has been found to be greater than that of fine particles, but NO2 is more stable in the 
atmosphere than ultrafine particles (Lewne et al., 2004). Thus NO2 might particularly be 
a good surrogate for the exposure to traffic-related pollutants. Overall, the central cite 
measurements of fine particulate pollutants are considered as better surrogates of personal 
exposure than measurements of gaseous pollutants (Sarnat et al., 2006).
An alternative way to assess exposure to ambient air pollutants is modeling. However, 
when modeling the exposure, measurement errors may not be efficiently adjusted, and 
therefore exposure misclassification cannot be wholly avoided (Ren and Tong, 2008).
2.3.2 Effects of PM10, PM2.5 and gaseous pollutants
The short-term health effects of ambient air pollutants have been widely described in the 
literature. The two largest multi-city studies examining the short-term health effects of 
air pollutants so far have been the European study APHEA, and NMMAPS in the United 
States (Katsouyanni et al., 1996; Samet et al., 2000). Following these two time-series 
studies, a similar study in Asia (PAPA study: Public Health and Air Pollution in Asia) is 
ongoing (HEI, 2008; Wong et al., 2008). APHEA and NMMAPS studies also emerged as 
an ongoing project “Air Pollution and Health: A European and North American Approach” 
(The European Commission, 2002). 
Several publications from APHEA and NMMAPS projects reported positive 
associations between various air pollutants and total mortality. In APHEA, 0.40% increase 
in total mortality in association with 10 µg/m3 change in PM10 was found (Katsouyanni et 
al., 1997). In NMMAPS, the corresponding increase in mortality was 0.27%, pooled over 
90 U.S cities (Dominici et al., 2005). 
Of the gaseous pollutants, CO and NO2 increased total mortality in the APHEA study 
(Samoli et al., 2006; Samoli et al., 2007). In NMMAPS the effect estimates for CO and NO2 
were positive though non-significant with one day delay (Dominici et al., 2005). However, 
ozone was linked with total mortality in both studies with 0.46% and 0.26% increase in 
total mortality (for 10 µg/m3 increase in ozone) in Europe and USA, respectively (Bell 
et al., 2004a; Touloumi et al., 1997). Elevated ozone levels have been found detrimental 
especially for the respiratory system also in several other studies (Anderson et al., 1997; 
Medina-Ramon et al., 2006; Spix et al., 1998; Yang et al., 2003). However, the effects 
of ozone should be interpreted with some caution because exposure assessment for 
ozone is difficult. No studies have determined the indoor-outdoor ratio of ambient ozone 
concentrations, and because ozone reacts readily with any surrounding surfaces, the indoor 
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concentrations can be remarkably lower than those measured outdoors. 
Since these two multi-city projects, air pollutant research has focused more on the 
smaller particles than PM10, especially on PM2.5. A 10 µg/m
3 increase in PM2.5 has been 
estimated to cause approximately 1% increase in cardiovascular mortality (Pope and 
Dockery, 2006). Findings of the time-series studies estimating the effects of PM2.5 and 
some other particulate measure on cardiovascular outcomes are listed in Table 1. Most 
studies found positive associations for fine and inhalable particles with cardiovascular 
mortality or morbidity. In about half of the studies, there were differences between particle 
fractions. In the other half of the studies presented in Table 1, the effect estimates were 
mostly comparable between different particle fractions. 
Table 1.  A summary of population level time-series studies estimating the health effects of more 
than one particulate fraction on cardiovascular health. Results are for one-pollutant analyses, 
covering the whole study period not restricted to seasons.
Particle 
size in µm 
Age 
(if not all)
Effect estimate for 
10 µg/m3 increase 
in PM10, PM2.5 or 
PM10–2.5
Lag Reference
All Cardiovascular Mortality
< 2.5
2.5–10
< 10
1.3 (–0.9–3.5) †
3.1 (0.0–6.2)
1.3 (–0.3–3.0)
1 (Lippmann et al., 2000)
< 2.5
< 15
1.17 (1.12–1.32)
1.11 (0.91–1.30)
1 (Tsai et al., 2000a)
< 0.1
< 2.5
0.45 (0.01–0.89)/1000
2.53 (0.22–4.89) *
0–5
0–4
(Wichmann et al., 2000)
< 2.5
< 10
>  65 7.1 (2.4–12) *  
1.6 (0.02–3.2)
1 (Mar et al., 2000)
< 2.5
2.5–10
< 10
2.7 (0.9–4.5) *
4.0 (0.9–7.1) *
7.6 (–5.6–22.5)
0 (Ostro et al., 2000)
< 2.5
2.5–10
< 10
1.55 (–1.25–4.35)
4.54 (1.55–7.52)
2.00 (0.39–3.60)
5-d mean (Castillejos et al., 2000)
< 2.5
< 10
1.3 (–0.5–3.2) †
0.9 (–0.3–2.1)
1 (Goldberg et al., 2001b)
< 2.5
< 10
0.5 (–1.2–2.3) †
0.4 (–0.79–1.63)
0-1-d mean (Anderson et al., 2001)
< 2.5
< 10
1.7 (–6.7–10.9)
2.2 (–1.7–6.2)
3–d mean (Villeneuve et al., 2003)
< 2.5
2.5–20
< 10
0.41 (0.01 − 0.82)
0.34 (–0.05 − 0.73)
0.31 (0.10 − 0.53)
0–1 (Kan et al., 2007)
Circulatory Mortality
< 2.5
< 10
2.9 (–4.2–10.5) * 
2.9 (–1.4–7.3)
1 (Ito, 2003)
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Particle 
size in µm 
Age 
(if not all)
Effect estimate for 
10 µg/m3 increase 
in PM10, PM2.5 or 
PM10–2.5
Lag Reference
All Cardiovascular Admissions
< 2.5
< 10
–0.25 (–1.3–0.79) †
–0.22 (–0.94–0.50)
0-1-d mean (Anderson et al., 2001)
< 2.5
< 10
3.3 (1.1– 5.6) *
0.9 (–0.2–2.1)
3-d mean (Metzger et al., 2004)
< 2.5
< 10
1.0 (–3.0–5.2) *
2.0 (–1.03–5.1)
3 (Slaughter et al., 2005)
< 2.5
< 10
≥  65 6.10 (1.0–11.4)
2.3 (0.8–3.9)
0-3-d mean (Andersen et al., 2007a)
< 2.5
2.5–10
0.9 (0.1–1.8)
0.5 (–1.2–2.3) 
0-1-d mean (Host et al., 2008)
< 2.5
2.5–10
0.71 (0.45–0.96)
0.36 (0.05–0.68)
0 (Peng et al., 2008)
Ischemic Heart Disease Admissions
< 2.5
< 10
≥  65 –0.15 (–2.3–2.1) †
0.78 (–0.73–2.3)
0-1-d mean (Anderson et al., 2001)
< 2.5
< 10
≥  65 4.8 (–2.7–12.9) *
4.2 (–0.2–8.8)
2 (Ito, 2003)
< 2.5
< 10
2.3 (–0.2–4.8) *
1.1 (–0.9–3.1
3-d mean (Metzger et al., 2004)
Heart Failure Admissions
< 2.5
< 10
5.5 (0.6–10.6) *
–0.8 (–3.2–1.7)
3-d mean (Metzger et al., 2004)
< 2.5
< 10
≥  65 10.6 (1.8–20.1) *
4.9 (–0.2–10.1)
1
0
(Ito, 2003)
Dysrhythmia Admissions
< 2.5
< 10
1.5 (–2.4–5.6) *
0.8 (–1.1–2.8)
0-2d mean (Metzger et al., 2004)
Peripheral Vascular Disease Admissions
< 2.5
< 10
5.0 (0.8–9.4) *
2.0 (–0.1–4.2)
0-2d mean (Metzger et al., 2004)
Stroke
< 2.5
< 10
≥  65 –0.8 (–3.4–1.8) †
–1.24 (–3.0–0.55)
0-1d mean (Anderson et al., 2001)
* Percent change / 10 µg m-3 increase in particle measure calculated from originally given effect estimate of RR
† Original percent change calculated for other volume than 10 µg m-3 (e.g. % / 14.6 µg m-3, or 36 µg m-3)
The effects of ambient air pollutants on respiratory health have generally been greater 
than the effects on cardiovascular diseases. One meta-analysis estimate presented in the 
literature suggests 1.3% increase in respiratory mortality for 10 µg m-3 increase PM10 
(Anderson, 2004) compared to 1% increase in cardiovascular mortality (Pope and Dockery, 
2006). The summary table of the time-series studies on respiratory outcomes shows that 
the sizes of the effect estimates between different particulate fractions have little variation 
(Table 2). On one hand, in five cases (Andersen et al., 2007a; Chen et al., 2004; Goldberg 
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et al., 2001a; Ito, 2003; Kan et al., 2007) the association for respiratory outcomes was 
found to be larger with PM2.5 than with PM10 or coarse particles. On the other hand, in 
five other cases the association with PM10 or coarse particles was stronger compared to 
that with PM2.5 (Andersen et al., 2007a; Atkinson et al., 2001; Castillejos et al., 2000; Peel 
et al., 2005). 
Table 2.  A summary of population level time-series studies estimating health effects of more than one 
particulate fraction on respiratory health. Results are for one-pollutant analyses, covering the 
whole study period not restricted to seasons.
Particle 
size in µm 
Age 
(if not all)
Effect estimate for 10 µg/m3 
increase in PM10, PM2.5, PM10–2.5 
or for 30 000/cm³ in UFPa
Lag Reference
All Respiratory Mortality
< 2.5
2.5–10
< 10
3.6 (–1.06–8.27)
8.03 (3.05–13.01)
3.85 (1.16–6.55)
5-d mean (Castillejos et al., 
2000)
< 2.5
2.5–10
< 10
0.9 (–4.3–6.4) †
2.9 (–3.7–10.0)
1.5 (–2.1–5.3)
0
2
0
(Lippmann et al., 
2000)
< 2.5
< 0.1 
1.8 (0.6–3.1) *
1.11 (0.42–1.80) 
0 (Wichmann et al., 
2000)
<2.5
2.5–10
< 10
–0.9 (–5.4–3.8) *
–1.9 (–9.5–6.3)
–11.8 (– 39–28)
0 (Ostro et al., 2000)
< 2.5
< 10
 ≥   65 5.1 (0.8–9.5) †
1.4 (–1.4–4.3)
1 (Goldberg et al., 
2001b)
< 2.5
< 10
–0.06 (–3.1–3.1) †
–0.58 (–2.52–1.41)
0-1-d mean (Anderson et al., 
2001)
< 2.5
< 10
3.0 (–13–22) *
4.0 (–5.8–14)
0 (Ito, 2003)
< 2.5
< 10
–0.8 (14.4–15.0)
0.0 (–6.2–6.7)
3-d mean (Villeneuve et al., 
2003)
< 0.1
< 2.5
16 (–5.3–43) †* 0 (Stolzel et al., 
2007)
<2.5
2.5–10
< 10
0.95 (0.16–1.73)
0.40 (–0.34–1.13)
0.33 (–0.08–0.75)
0–1 (Kan et al., 2007)
All Respiratory Admissions
< 2.5
< 10
0–14 1.7 (–0.05–3.5) †
1.4 (–0.2–2.7)
0-1-d mean (Anderson et al., 
2001)
< 2.5
< 10
15–64 –1.1 (–3.3–1.2) †
0.04 (–1.5–1.6)
0-1-d mean (Anderson et al., 
2001)
< 2.5
< 10
≥  65 –0.7 (–2.4–1.1) †
–0.4 (–1.6–0.8)
0-1-d mean (Anderson et al., 
2001)
< 2.5
< 10
1.0 (–2.0–4.1) *
1.0 (–2.7–4.8)
3 (Slaughter et al., 
2005)
< 2.5
< 10
≥  65 0.8 (–2.8–4.5) *
2.0 (–0.2–4.3)
0 (Fung et al., 2006)
< 2.5
< 10
≥  65 0.0 (–9.8–10.8) *
3.7 (1.6–5.9)
0-4-d mean (Andersen et al., 
2008)
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Particle 
size in µm 
Age 
(if not all)
Effect estimate for 10 µg/m3 
increase in PM10, PM2.5, PM10–2.5 
or for 30 000/cm³ in UFPa
Lag Reference
< 2.5
2.5–10
≥  65 0.5 (–2.0–3.0)
1.9 (–1.9–5.9)
0-1-d mean (Host et al., 2008)
< 2.5
2.5–10
0.44 (0.06–0.82)
0.33 (–0.21–0.86)
0
2
(Peng et al., 2008)
Asthma Admissions
< 2.5
< 10
≤18 2.4 (1.4–3.5) †
2.2 (1.6–2.7)
4 (Lee et al., 2006) 
< 0.1
< 2.5
–0.09 (–2.2–2.1)
0.5 (–2.2–3.3)
0-2-d mean (Peel et al., 2005)
< 2.5
< 10
5–18 32 (0.0–75) *
4.0 (–13.5–25.1)
0-5-d mean (Andersen et al., 
2008)
< 2.5
< 10
0.9 (0.4–1.4)
0.8 (0.4–1.2)
0-1-d mean (Ko et al., 2007)
Asthma–COPD Admissions
< 2.5
< 10
2.0 (–7.0–12) *
1.0 (–7.9–10.7)
3 (Slaughter et al., 
2005)
COPD Admissions
< 0.1 
< 2.5
–1.8 (–5.8–2.3)
1.5 (–3.1–6.3)
0-2-d mean (Peel et al., 2005)
< 2.5
< 10
≥  65 3.9 (–8.9–18.6) *
3.4 (–4.3–11.7)
3 (Ito, 2003)
< 2.5
< 10
≥  65 17 (4.6–31) *
10.9 (3.8–18.5)
0 (Chen et al., 2004)
< 2.5
< 10
adults 6.0 (–2.5–15.3) *
3.0 (–4.1–10.6)
2 (Slaughter et al., 
2005)
Pneumonia Admissions
< 2.5
< 10
≥  65 13 (2.5–26.6) *
9.4 (2.8–16.3)
1 (Ito, 2003)
< 0.1 
< 2.5
–2.2 (–4.7–0.2)
1.1 (–1.9–4.2)
0-2-d mean (Peel et al., 2005)
a  ultrafine particles, < 0.1µm
*  Percent change / 10 µg m-3 increase in particulate measure calculated from originally given effect estimate of RR
†  Original percent change calculated for other volume than 10 µg m-3 (e.g. % /14.6 µg m-3, or 36 µg m-3)
2.3.3 Effects of ultrafine and coarse particles
Besides PM10 and PM2.5, ultrafine particles have caught the interest of researches. In the 
first time-series studies using measured data on ultrafine particles, positive associations 
between ultrafine particles and all respiratory and asthma morbidity have been reported 
(Andersen et al., 2008; Peel et al., 2005). In both of these studies the associations with 
ultrafine particles were more than 2-days lagged. Similar effect lag structure was reported 
also in a German study on the effects of ultrafine particles on mortality (Breitner et al., 
2009; Stolzel et al., 2007; Wichmann et al., 2000). On the other hand, results of the multi-
city study HEAPSS, suggested more rapid effect of ambient particle number count on the 
Table 2. continued
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risk of first acute myocardial infarction and cardiac readmissions (Lanki et al., 2006b; 
von Klot et al., 2005), and in a case-crossover study in Italy, out-of-hospital coronary 
deaths were associated with the current-day levels of particle number count (a proxy for 
ultrafine particles) (Forastiere et al., 2005). However, only a few epidemiological time-
series studies, much less cohort studies, so far have been able to determine the health 
effects of ultrafine particles. Therefore, the current epidemiological evidence of the health 
effects of ultrafine particles still relies more on the results of panel studies that have been 
carried out among susceptible population groups. 
In panels among asthmatics, associations between ultrafine particles and respiratory 
health decrements have been reported in Finland and elsewhere (Ibald-Mulli et al., 2002; 
McCreanor et al., 2007; Penttinen et al., 2001a, b). In the ULTRA study, a decrease in LF/
HF ratio in association with ultrafine particles suggested that air pollution may lead to 
increased cardial vagal control (Timonen et al., 2006). In addition, in Germany ultrafine 
particles, among other air pollutants, have been linked to inflammatory responses among 
patients with coronary heart disease (Ruckerl et al., 2006; Ruckerl et al., 2007b). However, 
extrapolation of the result of panel studies to general population is not straightforward. 
In few experimental studies, healthy young people have been exposed to concentrated 
levels of ultrafine particles, and mild inflammatory and pro-thrombic responses have been 
observed also suggesting adverse effects caused by ultrafine particles (Samet et al., 2007; 
Samet et al., 2009). However, more research on the health effects of ultrafine particles on 
population level is needed. 
Health effects of coarse particles have been studied more often in time-series studies 
than the effects of ultrafine particles. In the U.S Six Cities Study, a 0.4% (95% CI -0.1–
1.0) increase in total mortality (for 10 µg/m3 coarse PM) was found (Klemm et al., 2000; 
Schwartz et al., 1996). Similarly, Peng et al. (2008) recently reported a 0.36% (95% 
posterior interval, 0.05%–0.68%) increase in cardiovascular disease admissions for 10 µg/
m3 increase in coarse particle concentration on the same day. However, this association 
was sensitive to adjusting for PM2.5 and the association between cardiovascular admissions 
and PM2.5 was greater than that of coarse particles. Positive association between coarse 
particles and respiratory hospitalizations among the elderly has also been reported in a 
Canadian study (3.96%, 95% CI 0.70–7.33, for 10 µm/m3) (Fung et al., 2006), and coarse 
particles have been found to affect heart rate variability and lipid parameters among 
asthmatic adults in North Carolina (Yeatts et al., 2007). The conclusion of the latest review 
on coarse particles by Brunekreef and Forsberg (2005) was that there is evidence of the 
health effects of coarse particles, but more research is still needed. 
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2.3.4  Effects of ambient particles from different sources
As the harmful effects of ambient particles on health have been found in many 
epidemiological studies (Tables 1 and 2), the limit and target levels have already been 
set for PM10 and PM2.5 (European Union, 2005; WHO, 2005). However, to be able to 
control for the most harmful particle emissions, the question of what sources emit the most 
harmful particles has to be thoroughly studied. 
Few epidemiological health studies have had data for the apportionment of various 
sources of measured ambient particles. There is some evidence showing that the effects 
of various PM2.5 components on health are different from each other. Most often, the 
harmful effects have been associated to traffic and combustion derived particles (Table 
3). Recently, for example, Sarnat et al. (2008) apportioned ambient PM2.5, and found 
that admissions for cardiovascular outcomes increased in association with PM2.5 from 
automobiles and biomass burning. They reported also associations between sulfate-rich 
secondary PM2.5 and respiratory morbidity. Local combustion particles and exposure to 
traffic have been linked to the decrease in lung function among asthmatics (McCreanor 
et al., 2007; Penttinen et al., 2006), and total and cardiovascular mortality have also been 
linked to traffic-related PM2.5 in several studies in the United States (Laden et al., 2000; 
Mar et al., 2000; Ostro et al., 2007). In two of these studies also PM2.5 from coal and 
biomass combustion affected mortality rates (Mar et al., 2000; Ostro et al., 2007). Traffic 
related particles seem to associate with the health outcomes in most studies presented in 
Table 3, whereas the effects of sea salt particles seem weaker.
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Table 3.  Studies that have determined the short-term health effects of source apportioned ambient particles. + indicates a positive finding between the 
particle source and a health outcome, - indicates that no health effects were observed, empty square indicates that the particle source was not 
identified.
Author Outcome
PM Source
Traffic Soil / Crustal
Oil 
combustion
Biomass 
combustion
LRT / 
Secondary 
sulphate
Sea 
Salt Other
Time-series studies
Mar  a
(2000)
Cardiovascular 
mortality + - + +
Laden  a
(2000) Total mortality + - -
Coal 
combustion
Tsai a
(2000a) Total mortality + - 
c + + Industrial
Janssen  b 
(2002)
Cardiovascular 
admissions + + -
Metal 
processing
Pneumonia 
admissions + - - -
Andersen b
(2007a)
Cardiovascular 
admissions - + + + + +
Respiratory 
admissions - + + + + +
Asthma admissions + - - - - -
Cardiorespiratory 
mortality - - + +
Sarnat  a 
(2008) Respiratory visits - - - +
Panel studies
Lanki  a 
(2006a)
ST segment 
depression + - - + -
Penttinen  a
(2006) PEF deviation + - - - -
Yue a
(2007)
Inflammatory marker 
C-reactive protein + + +
Re-polarization 
parameter + - -
Cardiovascular 
disease visits + - + -
Organic 
carbon
De Hartog  a  
(2009) Heart rate variability + - - + -
a  apportioned particulate measure was PM2.5 ,  
b  apportioned particulate measure was PM10 ,  
c Geological source
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2.3.5 Effects of pollutants in different age groups
Susceptibility to the effects of air pollutants among people at different ages has been 
hypothesized to differ. Most often children and the elderly are considered as the most 
sensitive population groups (Anderson et al., 2003; Goldberg et al., 2001c; Schwartz, 
2004). Even unborn children have been found to be at risk of the effects of pollutants when 
their mothers are exposed to air pollutants (Pereira et al., 1998; Salvi, 2007). In children, 
the defense mechanisms against xenobiotics are immature and therefore the ability to 
metabolize, detoxicify, and excrete environmental agents is lower than in adults (Kajekar, 
2007). The exposure to air pollutants is also higher among children because they have 
higher ventilation rates than adults, they are more active, spent more time outdoors, and 
they breath at the height of the traffic emission sources (Heinrich and Slama, 2007; Klepeis 
et al., 2001; Schwartz, 2004; Wigle et al., 2007). Another reason for the vulnerability 
may be that children tend to be mouth-, rather than nasal-, breathers, which suggests that 
pollutants reach lower parts of the lung, and that the composition of pollutants at alveolar 
level may be different from that of adults (Bateson and Schwartz, 2008). 
The elderly, on the other hand, often have underlying diseases that make them more 
vulnerable to the effects of air pollutants than adults (Anderson et al., 2003; Bateson and 
Schwartz, 2004; Peel et al., 2007). Aging causes biological changes in the body such as 
reductions in lung or cardiac function, and reduced resistance to infections. In addition, 
poor diet may occur more often among the elderly and that may also reduce the defense 
mechanisms against air pollutants. This is because the lack of antioxidants of dietary origin 
may reduce the protective mechanisms of the respiratory tract lining fluid that becomes 
first affected by inhaled air pollutants (Kelly et al., 2003). Exceeding the critical threshold 
of the health effects may thus occur after milder exposure to air pollution compared to 
individuals whose antioxidant intake is sufficient. At the same time, however, elderly 
people have been exposed to air pollutants during a longer time period, which may also 
cause chronic health effects (Anderson et al., 2003). 
2.4 Ambient air pollution studies in Finland
In Finland, the linkage between air pollution data and health effects has been studied 
since the late 1980’s when interest in the effects of low to moderate air pollution levels 
was aroused. Air pollution health studies have been possible due to the national health 
care system with high coverage, and extensive health, air pollutant, and meteorological 
data (Ponka, 1995). The earliest time-series studies in Finland were mainly performed 
by researchers Pönkä and Virtanen in Helsinki. Later, several researches have been 
performed with measurements from either Helsinki or Kuopio. These two cities have been 
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the companion cities in European multi-city projects such as PEACE, HEAPSS, APHEA 
(1 and 2), ULTRA and AIRGENE.
2.4.1 Population level time-series studies
Before investigations focused on the Helsinki metropolitan area, a study between air 
pollution and asthma emergency room visits was performed in Oulu (Rossi et al., 1993). 
In this study, authors found an association between asthma visits and ambient NO2, 
however, the data included measurements for only one year. The first population level 
time-series studies from Helsinki region included data for three years (1987–1989). 
These investigations revealed various associations between air pollutants and hospital 
admissions in the total population. Respiratory admissions were found to be associated 
with increases in SO2, NO2, and O3 at selected lags (Ponka and Virtanen, 1994, 1996a), 
and cardiovascular admissions seemed to be associated with NO (Ponka and Virtanen, 
1996b). First time-series studies on mortality had data over a longer time period from 1987 
to 1993. Cardiovascular mortality among people less than 65 years was linked to increases 
in PM10, O3, and NO2 (Ponka et al., 1998), and some years later (data for 1988–1996), 
respiratory mortality in the total population was also linked to increased  PM10 and O3 
levels (Penttinen et al., 2004).
However, the previous studies (Ponka and Virtanen, 1994, 1996a, b; Rossi et al., 1993) 
have had access to a limited number of measurement days and air pollution measures, 
and the health effects of ambient particles from different sources in Finland have not been 
determined in earlier time-series analyses. 
Helsinki was one of the participating cities in the APHEA (1985–1990) and APHEA 
II (1991–1996) projects where time-series method was used. Asthma hospital admissions 
of adults were found to be associated with the levels of gaseous pollutants SO2, NO2, 
and O3 in Helsinki (Sunyer et al., 1997). Positive associations of CO and NO2 with total 
and cardiovascular mortality were also reported, but in the city-specific analyses the 
associations in Helsinki were negative (Samoli et al., 2006; Samoli et al., 2007). Similarly, 
the association between cardiovascular mortality and PM10 in Helsinki was negative 
(Analitis et al., 2006). In agreement with previous results of Penttinen and co-workers 
(2004), respiratory mortality had a positive association with PM10 levels also in Helsinki 
(Analitis et al., 2006).
In the HEAPSS study, daily variation in hospital admissions for acute myocardial 
infarction (MI) in Helsinki (1993–1999) was investigated. Here, Lanki et al. (2006a) 
found that particle number count, a proxy for ultrafine particles, and CO were associated 
with an increase in MI admissions. Pooled relative risks for all five cities, and for Helsinki 
only were 1.005, 95% CI 0.996–1.015, and 1.041, 95% CI 0.970–1.117, respectively, 
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for 10 000 1/cm3 increase in particle number count. In this study, however, the particle 
number count measurements were performed only for one year and the rest of the data 
was modeled. In a cohort of myocardial infarction survivors in the HEAPSS study, an 
increased risk of hospital cardiac readmissions was observed in association with PM10 in 
Helsinki (von Klot et al., 2005).
2.4.2 Panel studies
More often than time-series studies, panel studies on the health effects of air pollutants 
have been carried out in Finland. The Finnish participant city in the PEACE study was 
Kuopio. The measurements for the panel of asthmatic children were carried out during 
winter 1993–1994. The main finding was that morning peak expiratory flow (PEF) was 
reduced in association with increase in PM10, TSP and NO2 with two days delay (Pekkanen 
et al., 1997; Timonen and Pekkanen, 1997). The participants of the PEACE study were 
included also in another panel that investigated the effects of particulate pollutants on 
PEF and respiratory symptoms (Tiittanen et al., 1999). In this study, some evidence of the 
associations between different ambient particulate size fractions and respiratory symptoms 
were observed.
Personal exposure to and the health effects of weekly averages of NO2 were studied 
among a panel of preschool children in Helsinki in 1990–1991. Respiratory symptoms were 
found to be associated with low levels of NO2 (Mukala et al., 1999). In a later panel study, 
in 1996–1997, asthmatic adults in Helsinki were investigated. Ultrafine and accumulation 
mode particles were associated with PEF and spirometric lung function decrements on the 
same and previous day (Penttinen et al., 2001a, b). These results suggested that traffic-
related pollutants (NO2 and ultrafine particles) exacerbate respiratory symptoms especially 
among asthmatics. Later on, analyses on the effects of fine particle sources on morning 
PEF among adult asthmatics led to a similar conclusion; PM2.5 from local combustion 
processes such as traffic, and from long-range transport were mainly responsible for the 
observed respiratory health effects (Penttinen et al., 2006). 
The international ULTRA study examined a panel of subjects with coronary heart 
disease during winter 1998–1999. Here, Pekkanen et al. (2002) found that ST-segment 
depression during exercise was associated with an increase in particles in the ultrafine 
and fine size fraction two days prior the test, which suggests that cardiovascular effects of 
particles can be partly due to myocardial ischemia. Other reported findings of the UTLRA 
study were a 2-day lagged association between ultrafine particles and Clara cell protein 
CC16, a marker of lung damage (Timonen et al., 2004), the association between shortness 
of breath and increases in PM2.5 levels at lags 0 to 3 days in Helsinki (de Hartog et al., 
2003), and a 0 to 2 days lagged association between heart rate variability and ultrafine and 
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fine particle levels (Timonen et al., 2006). Short-term, even hourly changes in the personal 
and outdoor PM2.5 levels were also associated with ST-segment depressions (Lanki et 
al., 2008), and 2 to 3-days lagged associations were reported between outdoor PM2.5 and 
decreased heart rate variability (de Hartog et al., 2009). The ULTRA study also tried to 
determine the most harmful particle sources. Similarly to the studies by Penttinen et al. 
(2006), and by Lanki et al. (2006b), the authors suggested that particles from combustion 
processes, mainly from local traffic, but also particles from long-range transport are the 
most harmful for health (de Hartog et al., 2009; Lanki et al., 2006a).
In the AIRGENE study associations between ambient air pollutants and inflammation 
markers were studied in six European cities. In the pooled analysis for the six cities, 
exposure to particle number count 12–17 hours prior the test increased IL-6 levels in blood 
(Ruckerl et al., 2007a). However, in Helsinki, a positive association was observed only for 
the change in blood fibrinogen level with particle number count and PM10 concentration. 
As described above, several associations have been found between air pollutants and 
health outcomes in panel studies in Finland. However, there are few limitations in panel 
studies, which is why also population level studies are needed. One is that the results 
can rarely be generalized across the total population, because panels are assembled of 
people with a specified underlying illness, who therefore are at higher risk to respond 
to air pollution exposure to begin with. Moreover, the outcomes studied in panel studies 
are usually sub-clinical changes, which means they are not as severe as hospitalizations 
or mortality that can be the outcomes in time-series and cohort studies. The study of rare 
diseases is neither possible in a panel, and often the low number of cases reduces the 
statistical power of the analyses (Lagorio et al., 2006). Benefits of panel studies include 
the possibility to study the mechanism that mediates the effects of air pollution. Repeated 
measurements can provide better power for the study and better adjustment for unknown 
confounders. More accurate personal exposure assessment is also possible in panel studies 
compared to time-series studies. However, this greatly increases the costs of the studies. 
In addition, the measurement periods in panel studies do not usually cover the whole 
year. Since particle mass compositions vary between seasons, because the particle source 
contributions are not the same through the year, the results may not be applicable to other 
seasons than that under investigation. 
2.4.3 Characteristics of air pollutants in Helsinki 
Helsinki metropolitan area is located in the Northern hemisphere by the Gulf of Finland. 
The location induces some characteristics to the air pollution levels in the area as wind 
from the sea dilutes the local emissions. Because of the marginal location, air pollutant 
levels, except for ozone, in Helsinki are generally low compared to big Central European, 
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North American or Asian metropolises. 
The prevailing south-western winds transport more than half of the total PM2.5 mass 
measured in Helsinki from Central European and Baltic countries, and from Russia 
(Kulmala, 2000; Vallius et al., 2003). The other half of particulate matter is derived from 
local sources and mainly from traffic, but also from coal and oil combustion processes, 
wood combustion, wearing of soil and roads, re-suspension of road dust, and from sea 
salt. The air quality guideline by WHO determines that the annual level of PM2.5 should 
be below 10 µg m-3 (WHO, 2005) – this is reached well in Helsinki with an average level 
of PM2.5 around 9 µg m
-3. 
The 24-hour average levels of inhalable particles, PM10, in Helsinki exceed the 
guideline level of 20 µg/m3 set by WHO (WHO, 2005) every year. This is because of the 
road dust episodes that occur at spring time. The dust derives from traction sanding that 
is necessary for the prevention of slipperiness of roads during winter, and also from the 
use of studded tires that leads to increased levels of asphalt aggregates (Kupiainen et al., 
2005). Other reasons for particulate matter episodes in Helsinki are particles from open 
biomass burning e.g. forest fires in Eastern Europe (Niemi et al., 2009).
Ultrafine particle levels in Helsinki, on the other hand, are similar to the levels in other 
big cities in Northern and Central Europe (Ruuskanen et al., 2001). This is because the 
sources of ultrafine particles are local and they are not affected by particles transported 
from elsewhere. Like anywhere, local combustion processes such as traffic are the main 
source of ultrafine particles in Helsinki. 
Like fine particles, ozone can be transported over long distances as it has been found to 
be associated to SO4
2- that is an indicator of long-range transport and secondary particles 
(Sarnat et al., 2001). Therefore long-range transportation from Central Europe affects also 
ambient ozone levels in Southern Finland (Laurila, 1999). The highest ozone levels are 
measured during the spring and summer time, when the temperature is favorable, and 
amount of sunlight is adequate for local ozone formation. At the same time, transportation 
of O3 during high pressure weather conditions can be intense. Guidelines for the ozone 
levels have also been determined by WHO (WHO, 2005). In Helsinki, the limit level for 
the maximum 8-hour moving average (100 µg m-3) is exceeded few times every year, most 
often during March or April.
The other gaseous pollutants, NO2 and CO, are mainly derived from traffic emissions 
in Helsinki, and the levels of these gases are generally below the limit levels. For example, 
in 2005, the level of NO2 exceeded the daily guideline level (70 µg m
-3) only few times 
in the very vicinity of busy roads in the city center. The exceeding of the limit value may 
have occurred because of inversion situations during winter time when pollutants cannot 
be mixed to larger air masses. However, the hourly NO2 values were constantly well 
below the maximum hourly guideline value (200 µg m-3) set by WHO. The levels of CO 
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in Helsinki are also frequently less than one tenth of the limit value (10 mg m-3, maximum 
8-hour moving average), set by the European Community.
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3 AIMs oF tHe stUDY
Continuous measurements of different ambient particle size fractions began in 1997 
in Helsinki. Together with regular monitoring data of other air pollutants there was an 
extensive database of air pollutant levels for a time-series analysis. Register-based health 
data over 7 years provided also high enough number of morbidity and mortality cases 
to attain statistical power for the analyses, and enough cases also for cause- and age- 
specified analyses.
The aims of this study were to determine
1)  Are there differences between the short-term effects of air pollutants on cause-
specific cardiovascular and respiratory health in Helsinki metropolitan area? 
2)  Which of the particle size fractions and PM2.5 sources are the most harmful for 
human health?
3)  Are there differences in the vulnerability to air pollutants between different age 
groups?
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4.1  Study area, mortality and morbidity data
The study measurements took place in the metropolitan area of Helsinki that consists of 
four municipalities: Helsinki, Vantaa, Espoo, and Kauniainen (one million inhabitants, 
745 km2) in 1998–2004. 
We obtained the daily mortality data from Statistics Finland, and acute hospital 
admission and emergency room visit data from National Research and Development 
Center for Welfare and Health (currently National Institute of Health and Welfare). 
Hospital admissions were collected from the hospital discharge registers from all hospitals 
in the study area, and only those cases when patient had stayed in the hospital over night, 
and did not come by appointment, were included. Hospital emergency room visits were 
derived from registers of three public hospitals that count in practice all emergency room 
visits in the study area. In the emergency room visit data we had cases only for asthma and 
chronic obstructive pulmonary disease (COPD) visits.  
For the definitions of the outcomes we used the codes of International Classification 
of Diseases 10th revision (ICD-10). For all cardiovascular diseases we used ICD-10 codes 
I00-I99. We determined the cardiovascular cause-specific effects of pollutants also for 
coronary heart diseases (I20-I25), myocardial infarctions (I21-I22), arrhythmia (I46.0, 
I46.9, I47-49), and stroke (I60-61, I63-64). Rest of the ICD-10 codes from classes I00-I99 
was determined as “other” cardiovascular diseases. For all respiratory diseases, we used 
ICD-10 codes J00-J99. The cause-specific respiratory outcomes studied were pneumonia 
(J12-J15, J16.8, J18), COPD (J41, J44), and asthma (J45, J46). Again, “other” respiratory 
diseases were determined as the rest of the codes of J00-J99. 
To examine whether the population groups differ in susceptibility to air pollutants, the 
analyses were performed separately for different age groups. However, the analyses were 
performed for all age groups only if the total number of cases in each analyzed outcome 
group was  ≥ 1 000. Age groups were those conventionally used in epidemiological studies; 
children were those less than 15 years old, adults those aged from 15 to 64 years and the 
elderly those aged 65 years or older. For adults and the elderly, the hospital admissions 
and emergency room visits for asthma and COPD were pooled to get a greater number 
of cases, especially for the emergency room visit analyses. To be consistent between 
analyses, pooled asthma-COPD data was used also for the hospital admissions. However, 
for mortality analyses, COPD was analyzed separately, because in the data there were only 
few deaths due to asthma (101 in total). 
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4.2 Measurement equipment and sites of pollutants
Particle number counts were measured with a differential mobility particle sizer of the 
University of Helsinki as described earlier (Hussein et al., 2005). Ten different particle 
fractions diameter ranging from 0.01 to 0.29 µm were separated and particles less than 
0.1 µm in diameter were counted as ultrafine particles. In the beginning of the study 
period, particle number counts were measured at a bank hill Siltavuori, a 20 meter high 
peninsula surrounded by urban areas, including downtown Helsinki at the distance of 
few hundred meters. In March 2001, the measurements started on a hilltop in Kumpula, 
located 3 km northeast of Siltavuori. In Kumpula, the measurements were conducted on 
the fourth floor of an office building (20 meters in height) where there is a major highway 
at a distance of 100 meters. Particle counts at these two sites correlated well with each 
other (Hussein et al., 2004b). Measurement site change was also taken into account in the 
statistical analyses by using a dummy variable.
Particle mass measurements (PM2.5, PM10) were performed using beta-attenuation 
method (FH 62 I-R; Eberline Instruments). Carbon monoxide was measured with a 
non-dispersive infrared monitor (CO-11 M, Environnement SA), NO2 with continuous 
monitoring device (Horiba APNA 360, HORIBA International Corp), and SO2 with 
automated equivalent method (Thermo Electron Model 43A, Thermo Environmental 
Instrumentation). In the beginning, the measurements of PM2.5, PM10, NO2, CO, and SO2 
were performed at the same site. Monitors were located in Vallila in a park 14 meters from 
the closest road. Later (from the beginning of 2004), the particulate mass monitoring was 
conducted in Kallio at a sports area, where the nearest busy road was 80 m away from the 
site. These two measurement sites for particles were only one kilometer apart from each 
other. The mass of coarse particulate matter was obtained (PM10-2.5) by subtracting daily 
levels of PM2.5 from PM10. The measurements of SO2 were only used in the analysis of 
PM2.5 source apportionment.
Ozone was measured (Thermo Environmental Instrumentation Model 49/49C) at a 
site representing background concentrations in the Helsinki metropolitan area. The site 
located at a distance of 200 m from the closest busy road and 15 km from the Helsinki 
city center. The O3 levels around the measurement site are affected by pollutants from 
long-range transport, and local traffic. Missing values in the whole air pollution data were 
replaced with data from measurement sites that were most identical with the primary site, 
for example the traffic volumes around both sites were similar. The correlation between 
the 24-h PM2.5 and PM10 measurements between Kallio and Vallila sites, for example, 
were 0.95 and 0.93, respectively.
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4.3  Confounders; meteorology, influenza and pollen 
count 
Daily meteorological data for the study was gathered from the same locations as 
particulate mass measurements. As possible confounders in the models we used variables 
for temperature, relative humidity, and barometric pressure. 
We obtained weekly influenza counts from the Infectious Diseases Register of 
National Institute of Health and Welfare. We created a three-class dummy variable for 
influenza epidemics by using < 35 (cumulative percentage 79), 35–179 (80–94%), and 
≥ 180 (≥  95%) cases per week as the cut points. The influenza data was rightly skewed i.e. 
the number of those days with no influenza cases at all was large compared to days with 
influenza cases. This is typical for influenza, since influenza often occurs as epidemics 
mainly during the cold season. Data with numerous zero value days would have made the 
continuous influenza variable unsteady.
Daily pollen counts for the six months “pollen period” were derived from the Aerobiology 
Unit of University of Turku. Pollen measurements in Helsinki were performed on a roof 
top located approximately 4 km from the particulate measurement sites. Measurements for 
pollen counts were conducted from the beginning of March to the end of August, which 
is the pollen period in Finland, each year.  Similarly to influenza counts, a dummy for 
the pollen episodes was created using the daily pollen count sum ≥  100 of the four most 
allergenic species (Birch, Mugwort, Alder, Grass) as the cut point. 
4.4  Statistical analyses
4.4.1  Time-series analysis
The core models were first built without the air pollutant and the dummy variable for the 
measurement cite change. Time trend, as continuous variable, and a dummy variable for 
weekday were always in the models as were variables for the current day mean temperature, 
relative humidity and barometric pressure. The significance of other confounders, 3 
previous days’ mean temperature and relative humidity, and the significance of dummy 
variables for influenza epidemics, high pollen episodes, and general holidays were always 
checked. These confounders were dropped from the model if their p > 0.20. The time-
series analyses of the associations for the air pollutants with mortality and morbidity were 
conducted with Poisson regression. The formula for the model used was: 
ln[E(yt)]=a0+β*et +Σfj(xtj) +Σβdzd 
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where yt= daily number of cases, e=exposure of interest, x=time-varying and z=non-time-
varying variables. 
In the articles I-III, penalized thin plate regression splines in the generalized additive 
models (GAMs) framework were used (Wypij, 1996). This method is often used in air 
pollution time-series studies (Dominici et al., 2002) as many of the confounding parameters, 
like temperature, are not linear, but can be controlled for with this model better than with 
ordinary Poisson regression. The linearity of the possible confounding variables in the 
model was always tested. If the effective degree of freedom for the smooth term for each 
confounding variable in the model was more than 1.5, the variable was considered to be 
non-linear. Additionally, plots of the associations between the outcome and the possible 
confounder were studied to find out whether the association was linear. Smoothing was 
then applied for all non-linear variables in the final model. Modeling was implemented 
using R software (2.0.0, 2.6.0 and 2.7.1) (R Development Core Team, 2008), and the mgcv 
procedure (1.3–7, 1.4–0) (Wood, 2000). 
For ozone (article IV), however, the analyses were performed slightly differently. 
Because there was more autocorrelation in the residuals in the generalized additive model 
we used robust Poisson regression models that can better control for autocorrelations. 
The core model was built using a GAM and without the air pollutant. In this model, the 
long-term time trend was controlled for by dummy variables for each year and month that 
were always in the model. Other possible confounders were the same as above. Penalized 
spline smoothing was used to examine the shape of association between weather variables 
and mortality or morbidity counts, which all turned out to be linear. Finally, the analyses 
of the associations between ozone and mortality and morbidity were conducted with 
robust Poisson regression. Robust standard errors of the estimates were used to account 
for the heteroskedasticity and the observed autocorrelation in the residuals. Modeling was 
implemented using the Zelig package in R (Imai et al., 2007, 2008) based on the models 
built using GAM. 
The models were built for all outcomes also by warm (May-September) and cold 
(October-April) season. The division of the seasons was based on the temperature variation 
in the study area. During the cold season months there were days when temperature 
dropped below 0°C.  
In the models, the 24-hour average concentrations for particulate mass and NO2, and 
24-hour median counts for ultrafine (< 0.1 µm), nucleation (0.01–0.03 µm), Aitken (0.03–
0.1 µm), and accumulation (0.1–0.29 µm) mode particles were used. Use of medians for 
the particle counts was due to the rightly skewed distribution of particles. For O3 and CO, 
the 8-hour maximum moving averages were used because the guideline and limit levels 
for these pollutants are given in this unit following the measurement recommendations by 
WHO (WHO, 1999), and because of better comparability with previous studies
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In advance, it was chosen that analyzes are performed for the effects of zero to five 
days prior the event, which is a longer period than determined in most previous studies. 
Averages of lag days 0 and 1 (2-day mean), and lag days 0 to 4 (5-day mean) were also 
analyzed. Lag 0 is the concentration measured during the 24-hour period from midnight 
to midnight at the day of event, or in the case of O3 and CO, the 8-hour maximum moving 
average concentration at the day of death, hospitalization, or emergency room visit. 
Some sensitivity analyses were performed for all models. A partial autocorrelogram of 
the residuals was used to define the amount of autocorrelation in the residuals and to avoid 
over-smoothing. Moreover, the analyses were run using the same lag for temperature 
and the pollutants in the models. In order to study the possible confounding effect of co-
pollutants, two-pollutant models were also run for those models that provided significant 
associations in the single-pollutant analyses. The differences in asthma and asthma-COPD 
coefficients of pollutants between the age groups and between lag days were tested with a 
t-test assuming 0 covariance between the coefficients (i.e. using the formula): 
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β β
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Finally, to see whether peak concentrations affected the results, analyses were performed 
only for days when pollutant concentration was below the 98th percentile of the maximum 
concentration measured for each pollutant.
4.4.2 Source apportionment of PM2.5
Sources of PM2.5 were determined using EPA PMF 1.1 model. PMF is an advanced 
multivariate receptor modeling technique that calculates site-specific source profiles and 
source contributions (Paatero, 1997). EPA PMF 1.1 solves the general receptor model 
using constrained, weighted least-squares as implemented in the program ME2 (Paatero, 
1999). 
Missing, negative and null values in the data were replaced by geometric means of the 
measures, and these values were weighted down by four. This guaranteed that the replaced 
value had minor effect on the analysis, but all other values of that day could be used, and 
no data was missed. The model calculates two matrixes; one combining the sources and 
pollutants and one combining the power of sources and pollutants. When multiplying 
these matrixes we got the included pollutants apportioned into different sources. 
For source identification, a priori knowledge concerning chemical and physical 
profiles of sources can be used (Grahame and Hidy, 2007; Sarnat et al., 2008). Because 
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no elemental data was available for this study, factor analysis was performed using daily 
averages of particulate and gaseous pollutants that are known to originate from emissions 
of different sources. Models were run assuming three, four, or five factors. The four factor 
model was found to be physically the most interpretative.
One factor, which was named traffic-related PM2.5, was found to be high in NC33-45 
(number concentration of particles 33–45 nm in diameter), NC84–114 (number concentration 
of particles 84–114nm in diameter), NO2, and CO, which indicate traffic-related particles. 
NC33-45 relates especially to gasoline emissions (Ristovski et al., 1998), while high 
concentrations of NC84–114 indicate diesel emissions (Morawska, 1998). 
A second factor was named as soil PM2.5, as it was found to have high loading of 
coarse particles, PM10–PM2.5, which indicate particles mainly from soil and road dust, but 
also particles from sea salt. Particles from soil and re-suspension of road dust, and from 
other mechanical processes are present mainly in the coarse size fraction (Seinfeld and 
Pandis, 2006), but they also have a contribution to PM2.5. 
In Helsinki, SO2 has been associated with coal/oil combustion (Vallius et al., 2003), 
and therefore the third factor that was high in SO2 was named coal/oil combustion PM2.5
The fourth factor with high loading of particulate SO4
2- was named as long-range 
transport PM2.5. Secondary sulfate is formed in the atmosphere by oxidation of SO2 
(Grahame and Hidy, 2007) and therefore these particles refer to long-range transport (Niemi 
et al., 2004). Concentration of particulate SO4
2- was measured at EMEP background station 
at Virolahti (60°32’N, 27°41’E). Correlation between the Virolahti SO4
2- and Helsinki S 
was reasonable (r = 0.75) for the time period of 2.11.1998–30.4.1999 (unpublished data). 
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We identified 4 sources for PM2.5. One factor was formed of secondary sulfate and other 
long-range transported particles, and the factor’s average source contribution was 5.5 µg/
m3 or 57%. The factor describing traffic emissions was characterized by NO2, CO, NC33–
45, and NC84–114. The average source contribution of traffic factor was 1.8 μg/m3, and it 
explained, on average, 19% of the PM2.5 mass. The average source contribution of the third 
factor, soil and road dust fraction was 1.0 µg/m3 (10%). This factor described road dust 
re-suspended by traffic or wind, and other sources of soil-related or coarse particles. The 
fourth factor was characterized by SO2 that, in Helsinki, describes mostly coal combustion 
emissions and emissions from ship engines that burn residual oil. The average source 
contribution of the fourth factor was 0.5 µg/m3 (6%). 
The numbers of mortality, hospital admission and emergency room visit counts are given 
in the original publications (I-IV). The summary of the levels of air pollutants in Helsinki 
during the whole year, and during warm and cold seasons in 1998-2004 is presented in the 
Appendix Table 1 of this doctoral dissertation. In addition, the correlations of the pollutants 
and environmental factors by warm and cold season are provided in the Appendix Tables 2 
and 3, and the percent contributions of each PM2.5 source to the total PM2.5 mass, and the 
levels of source-specific PM2.5 by season are presented in the Appendix Table 4. 
In the result tables and figures presented in this dissertation, three particle measures 
-ultrafine, fine and coarse particles- are presented for the health outcomes where positive 
associations with particles were observed. These particle fractions were chosen because 
ultrafine particles describe rather well also the associations observed for nucleation and 
Aitken mode particles, and results for PM2.5 are similar to those found for accumulation 
mode particles. Comparison of the results to the literature is also more straightforward 
when using these particulate measures. Presenting the same particle fractions in all figures 
makes the comparison of the associations between health outcomes and between age 
groups possible. Some figures also provide additional results –more lag days and different 
pollutants- to those published in the articles I–IV to give a wider perspective of the findings 
of this study. All presented results in figures are from one pollutant analyses, and results 
for 5 lag days are provided. 
As a partial overview of the study results, positive findings between ambient particulate 
pollutants and health effects among the elderly in the whole year analyses and during the 
warm season are summarized in Tables 4 and 5, respectively. Cold season results are 
not provided because hardly any associations were observed. A plus mark in the table 
means that a borderline significant effect or an isolate significant effect was observed. Two 
plusses mean that there was a strong positive and significant effect observed, and that the 
association was seen for more than one lag.
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Table 4.  Summary of the positive associations between particulate matter and cardiorespiratory health 
among the elderly in 1998–2004 in Helsinki.
Outcome
Particulate pollutant PM2.5 Source
Ultrafine 
particles PM2.5
Coarse 
PM LRT* Traffic Soil
Coal/Oil
combustion
Mortality
All cardiovascular
Stroke +
CHD
Arrhythmia NA NA NA NA NA NA NA
All respiratory + + +
Pneumonia + +
COPD 
Hospital admissions
All cardiovascular + + +
Stroke
CHD
Arrhythmia + +
All respiratory ++ + +
Pneumonia ++
Asthma-COPD ++ ++ ++ + +
Other ++ + +
*  Long-range transport
+  Isolate significant or borderline significant association 
++ Significant (p-value < 0.05) and association seen for more than one lag
NA not applicable because number of cases < 1000
Table 5.  Summary of the positive associations between particulate matter and cardiorespiratory health 
among the elderly in 1998–2004 in Helsinki during the warm season (May-September).
Outcome
Particulate pollutant PM2.5 Source
Ultrafine 
particles PM2.5
Coarse 
PM LRT * Traffic Soil
Coal/Oil
combustion
Mortality
All cardiovascular + + +
Stroke ++ + + ++
CHD
Arrhythmia NA NA NA NA NA NA NA
All respiratory ++
Asthma-COPD NA NA NA NA NA NA NA
Pneumonia NA NA NA NA NA NA NA
Hospital admissions
All cardiovascular + +
Stroke
CHD +
Arrhythmia + + +
All respiratory ++ +
Pneumonia ++ ++
Asthma-COPD ++ +
Other ++ ++
*  Long-range transport
+  Isolate significant or borderline significant association 
++ Significant (p-value < 0.05) and association seen for more than one lag
NA not applicable because number of cases < 1000
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5.1  Cardiovascular health effects of ambient particulate 
and gaseous pollutants
The associations between ambient air pollutants and cardiovascular mortality and morbidity 
were determined only for adults and the elderly, because there were an insufficient number 
of death and admission cases among children. 
Consistent positive associations were not found between particulate pollutants and 
cardiovascular mortality of adults or the elderly in the whole year analyses (article III). 
Total cardiovascular mortality among the elderly showed positive association only with 
PM2.5 during the warm season with increase of 7.29% (95% CI 1.32–13.6) for 10 µg/m
3. 
However, a 2 to 3 days lagged negative association was observed between cardiovascular 
mortality of the elderly and ozone during the warm season (article IV). Among adults, the 
warm season associations for cardiovascular mortality with particulate mass were mainly 
negative (Appendix Table 5), but with ozone there was a positive association (article IV). 
However, the association with ozone was sensitive to adjusting for PM2.5. 
In the cause-specific mortality analyses, stroke mortality explained the found warm 
season association between PM2.5 and cardiovascular mortality among the elderly (article 
I). However, in the analyses of hospital admissions, we did not find such an association 
between stroke and fine particles, but a 2-days lagged negative association was observed 
for stroke admissions with accumulation mode particles (article III) and with PM2.5 
(Figure 3).
For cause-specific cardiovascular hospital admissions, the only positive associations 
with particles were 4 days lagged and found among the elderly. Associations were found 
for arrhythmia and stroke admissions with ultrafine and Aitken mode particles (Figure 3. 
article III). However, the associations for arrhythmia and stroke admissions with coarse 
particles were mainly towards negative direction (Figure 3). Arrhythmia admissions of the 
elderly were also associated with ozone during the warm season, however, the association 
was somewhat confounded by PM2.5 (article IV). 
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I). However, in the analyses of hospital admissions, we did not find such an association 
between stroke and fine particles, but a 2-days lagged negative association was observed 
for stroke admissions with accumulation mode particles (article III) and with PM2.5 (Figure 
3). 
For cause-specific cardiovascular hospital admissions, the only positive associations 
with particles were 4 days lagged and found among the elderly. Associations were found for 
arrhythmia and stroke admissions with ultrafine and Aitken mode particles (Figure 3. article 
III). However, the associations for arrhythmia and stroke admissions with coarse particles 
were mainly towards negative direction (Figure 3). Arrhythmia admissions of the elderly 
were also associated with ozone during the warm season, however, the association was 
somewhat confounded by PM2.5 (article IV).  
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* Arrhythmia model adjusted for time trend, weekday, holiday, influenza epidemics, temperature (lag 0 and 
1-3d mean), relative humidity (lag 0 and 1-3d mean), and barometric pressure *  Arrhythmia model adjusted for time trend, weekday, holiday, influenza epidemics, temperature (lag 0 and 1–3d mean), relative 
humidity (lag 0 and 1–3d mean), and barometric pressure
†  Stroke model adjusted for time trend, weekday, holiday, temperature (lag 0 and 1–3d mean), relative humidity (lag 0 and 1–3d 
mean), and barometric pressure
Figure 3.  Percent change (95% CI) in arrhythmia and stroke hospital admissions of the elderly for an 
interquartile increase in ambient particulate pollutants in 1998–2004 in Helsinki.
53JAANA HALONEN:  ACUTE CARDIORESPIRATORY HEALTH EFFECTS OF SIZE-SEGREGATED AMBIENT 
PARTICULATE AIR POLLUTION AND OZONE
5  RESULTS
5.2 Respiratory health effects of ambient particulate and 
gaseous pollutants
The associations between pollutants and respiratory mortality were determined only for 
the elderly, because the number of cases was less than 1000 among adults and children. 
Total respiratory mortality of the elderly was associated with particulate matter at 0 to 1 
day lags (article III), and similar effect was found in cause-specific analyses for pneumonia 
mortality (article III). 
The associations between pollutants and respiratory morbidity were evaluated using 
hospital admission and hospital emergency room visit counts. These analyses were 
performed for all three age groups. All respiratory, pneumonia, and asthma-COPD 
hospital admissions as well as asthma-COPD emergency room visits of the elderly were 
associated with four different particulate fractions, namely Aitken, accumulation, and 
coarse mode particles, and PM2.5, and also with CO in the whole year analyses (articles 
II and III). In Figure 4, associations for three of the particle fractions with pneumonia and 
asthma-COPD hospital admissions of the elderly are presented. During the warm season, 
associations between particulate pollutants and respiratory admissions of the elderly were 
generally stronger than in the whole year analyses (article III). Ozone had also positive 
association with asthma-COPD admissions of the elderly during the warm season (article 
IV and Figure 5).
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* Pneumonia model adjusted for time trend, weekday, influenza epidemics, temperature (lag 0), relative 
humidity (lag 0), and barometric pressure 
† Asthma-COPD model adjusted for time trend, weekday, influenza epidemics, high pollen episodes, 
temperature (lag 0), relative humidity (lag 0 and 1-3d mean), and barometric pressure 
 
Figure 4. Percent change (95% CI) in pneumonia and asthma-COPD hospital admissions 
of the elderly for an interquartile increase ambient particulate pollutants in 1998-2004 in 
Helsinki. 
 
 
 
*  Pneumonia model adjusted for time trend, weekday, influenza epidemics, temperature (lag 0), relative humidity (lag 0), and 
barometric pressure
†  Asthma-COPD model adjusted for time trend, weekday, influenza epidemics, high pollen episodes, temperature (lag 0), relative 
humidity (lag 0 and 1–3d mean), and barometric pressure
Figure 4.  Percent change (95% CI) in pneumonia and asthma-COPD hospital admissions of the elderly for 
an interquartile increase ambient particulate pollutants in 1998–2004 in Helsinki.
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* Model for children adjusted for year, month, weekday, holiday, high pollen episodes, temperature (lag 0), 
relative humidity (lag 0), and barometric pressure 
† Model for adults adjusted for year, month, weekday, holiday, high pollen episodes, temperature (lag 0), 
relative humidity (lag 0), and barometric pressure 
‡ Model for the elderly adjusted for year, month, weekday, high pollen episodes, temperature (lag 0), relative 
humidity (lag 0 and 1-3d mean), and barometric pressure 
 
Figure 5. Percent change in emergency room visits for asthma among children, and in 
hospital admissions for asthma-COPD among adults and the elderly for an interquartile 
change in O3 in single pollutant model and in model adjusted to PM2.5 in 1998-2004 in 
Helsinki. 
 
 
We observed only few positive associations between particulate pollutants and all 
respiratory hospital admissions of adults. However, both asthma-COPD admissions and 
emergency room visits among adults were positively, although non-significantly, associated 
*  Model for children adjusted for year, month, weekday, holiday, high pollen episodes, temperature (lag 0), relative humidity (lag 
0), and barometric pressure
†  Model for adults adjusted for year, month, weekday, holiday, high pollen episodes, temperature (lag 0), relative humidity (lag 0), 
and barometric pressure
‡  Model for the elderly adjusted for year, month, weekday, high pollen episodes, temperature (lag 0), relative humidity (lag 0 and 
1–3d mean), and barometric pressure
Figure 5.  Percent change in emergency room visits for asthma among children, and in hospital 
admissions for asthma-COPD among adults and the elderly for an interquartile change in O3 in 
single pollutant model and in model adjusted to PM2.5 in 1998–2004 in Helsinki.
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with changes in the current and previous-day levels of all particulate measures (article II and 
Figure 6). There was also a negative association between pneumonia admissions among 
adults and coarse particles at lag 2 (Figure 6). 
 
Day lag
%
 C
ha
ng
e 
Pn
eu
m
on
ia
 * 
/ I
Q
R
 
0 1 2 3 4 5
0
10
Ultrafine PM
Day lag
 
0 1 2 3 4 5
0
10
PM2.5
Day lag
 
0 1 2 3 4 5
0
10
Coarse
Day lag
%
 C
ha
ng
e 
As
tm
a-
C
O
PD
 †
 / 
IQ
R
 
0 1 2 3 4 5
0
10
Day lag
 
0 1 2 3 4 5
0
10
Day lag
 
0 1 2 3 4 5
0
10
 
* Pneumonia model adjusted for time trend, weekday, holiday, influenza epidemics, temperature (lag 0 and 1-
3d mean), relative humidity (lag 0 and 1-3d mean), and barometric pressure 
† Asthma-COPD model adjusted for time trend, weekday, influenza epidemics, high pollen episodes, 
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Figure 6. Percent change (95% CI) in pneumonia and asthma-COPD hospital admissions 
of adults for an interquartile increase in ambient particulate pollutants in 1998-2004 in 
Helsinki. 
 
 
*  Pneumonia model adjusted for time trend, weekday, holiday, influenza epidemics, temperature (lag 0 and 1–3d mean), relative 
humidity (lag 0 and 1–3d mean), and barometric pressure
†  Asthma-COPD model adjusted for time trend, weekday, influenza epidemics, high pollen episodes, temperature (lag 0), relative 
humidity (lag 0 and 1–3d mean), and barometric pressure
Figure 6.  Percent change (95% CI) in pneumonia and asthma-COPD hospital admissions of adults for an 
interquartile increase in ambient particulate pollutants in 1998–2004 in Helsinki.
We observed only few positive associations between particulate pollutants and all 
respiratory hospital admissions of adults. However, both asthma-COPD admissions and 
emergency room visits among adults were positively, although non-significantly, associated 
with changes in the current and previous-day levels of all particulate measures (article 
II and Figure 6). There was also a negative association between pneumonia admissions 
among adults and coarse particles at lag 2 (Figure 6).
Among children, increases in PM2.5 and coarse mode particle levels increased hospital 
admissions for all respiratory diseases during the whole year, and the warm season (Appendix 
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Table 6). However, coarse particles had positive association also with all respiratory hospital 
admissions and asthma emergency room visits during the cold season (Appendix Table 6 
and Figure 7). Strong associations were found in the whole year analyses between asthma 
emergency room visits and traffic-related pollutants; ultrafine particles, NO2 and CO 
(article II). In the season-specific analyses for children, the association between ultrafine 
particles and asthma visits emerged during the cold season. PM2.5 and coarse particles had 
positive association with asthma visits during the warm season, however, associations were 
observed at different lags (Figure 7). Ozone had also a strong association with the asthma 
visits of children during the warm season (article IV and Figure 5). 
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Among children, increases in PM2.5 and coarse mode particle levels increased hospital 
admissions for all respiratory diseases during the whole year, and the warm season 
(Appendix Table 6). However, coarse particles had positive association also with all 
respiratory hospital admissions and asthma emergency room visits during the cold season 
(Appendix Table 6 and Figure 7). Strong associations were found in the whole year analyses 
between asthma em rgency room visits and tra fic-related pollutant ; ultr f ne particl s, NO2 
and CO (article II). In the season-specific analyses for children, the association between 
ultrafine particles and asthma visits emerged during the cold season. PM2.5 and coarse 
particles had positive association with asthma visits during the warm season, however, 
associations were observed at different lags (Figure 7). Ozone had also a strong association 
with the asthma visits of children during the warm season (article IV and Figure 5).  
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 *  Warm season model adjusted for time trend, weekday, holiday, influenza epidemic, high pollen episode, temperature (lag 0 and 
1–3d mean), relative humidity (lag 0 and 1–3d mean), and barometric pressure
†  Cold season model adjusted for time trend, weekday, holiday, influenza epidemics, temperature (lag 0 and 1–3d mean), relative 
humidity (lag 0 and 1–3d mean), and barometric pressure
Figure 7.  Percent change (95% CI) in asthma emergency room visits of children for an interquartile 
increase in ambient particulate pollutants during warm and cold season in 1998–2004 in 
Helsinki.
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Two-pollutant analyses were run as sensitivity analyses to see if other pollutants have 
confounding effect on the associations observed. Nitrogen dioxide seemed to confound 
the associations of ultrafine particles. The results for the single- and two-pollutant analyses 
for asthma and asthma-COPD emergency room visits among children and the elderly, 
respectively, are provided in Table 6. The presented lags are those where strong positive 
associations were observed for particulate measure in single-pollutant analyses, i.e. 2-d 
mean for the elderly where significant association with PM2.5 was observed, and lag day 4 
for children where significant association with ultrafine particles was observed.
Table 6.  Percent change (95% Confidence Interval) in emergency room visits for asthma–COPD among 
the elderly and asthma among children for an interquartile increase in pollutants, in 1998–
2004. Results for single– and two–pollutant models.
Single 
Pollutant
Model
With CO With NO2
With 
ultrafine 
particles
With PM2.5
With Coarse 
PM
Asthma-COPD Elderly (2-d mean)
Ultrafine 
particles
2.64
(–1.28–6.71)
0.87
(–3.29–5.20)
–0.52
(–5.30–4.50)
– 2.14
(–1.47–5.88)
1.96
(–2.16–6.24)
PM2.5 3.32 
a
(0.93–5.76)
2.68  a
(0.16–5.326
2.52  b
(–0.09–5.21)
3.10 a
(0.55–5.72)
– 3.18 a
(0.66–5.76)
Coarse 
PM
1.90
(–0.64–4.51)
1.30
(–1.28–3.96)
0.92
(–1.79–3.71)
1.41
(–1.21–4.10)
0.83
(–1.84–3.58)
–
Asthma Children (Lag 4)
Ultrafine 
particles
6.06 a
(2.34–11.0)
6.22  a
(1.59–11.1)
–0.98
(–6.11–4.62)
– 6.16  a
(1.66–10.9)
6.59 a
(2.08c11.3)
PM2.5 2.56 
 b
(–0.17–5.36)
0.19
(–0.10–0.47)
0.00
(–0.30–0.29)
1.44
(1.44–4.41)
– 1.20
(–1.72–4.22)
Coarse 
PM
1.21
(–1.67–4.17)
0.57
(–2.38–3.61)
–1.97
(–5.04–1.21)
0.75
(–2.24–3.83)
0.86
(–2.17–3.99)
–
a  p < 0.05
b  p < 0.10
5.3  Health effects of source-specified PM2.5
Cardiovascular outcomes were not associated with source apportioned PM2.5, as there were 
few associations between cardiovascular health and particulate matter in general (article 
III). Total respiratory mortality and morbidity of the elderly had positive associations with 
PM2.5 from long-range transport, traffic and soil (article III). Particles derived from the 
same three sources had positive, though non-significant, associations also with asthma-
COPD morbidity of the elderly and adults (articles II and III, Figure 8). Traffic-related 
particles had a strong and delayed association with exacerbation of asthma in children 
(article II, Figure 8). Figure 8 presents the associations observed for PM2.5 from traffic and 
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long-range transport with the emergency room visits for asthma among children and for 
asthma-COPD among adults and the elderly. Particles from these two sources had more 
significant associations with respiratory morbidity than soil or coal and oil combustion 
particles.
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5.3 Health effects of source-specified PM2.5 
 
Cardiovascular outcomes were not associated with source apportioned PM2.5, as there were 
few associations between cardiovascular health and particulate matter in general (article III). 
Total respiratory mortality and morbidity of the elderly had positive associations with PM2.5 
from long-range transport, traffic and soil (article III). Particles derived from the same three 
sources had positive, though non-significant, associations also with asthma-COPD morbidity 
of the elderly and adults (articles II and III, Figure 8). Traffic-related particles had a strong 
and delayed association with exacerbation of asthma in children (article II, Figure 8). Figure 
8 presents the associations observed for PM2.5 from traffic and long-range transport with the 
emergency room visits for asthma among children and for asthma-COPD among adults and 
the elderly. Particles from these two sources had more significant associations with 
respiratory morbidity than soil or coal and oil combustion particles. 
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*  Model for children adjusted for time trend, weekday, influenza epidemics, high pollen episodes, temperature (lag 0 and 1–3d 
mean), relative humidity (lag 0 and 1–3d mean), and barometric pressure
†  Model for adults adjusted for time trend, weekday, influenza epidemics, high pollen episodes, temperature (lag 0 and 1–3d 
mean), relative humidity (lag 0), and barometric pressure
‡  Model for the elderly adjusted for time trend, weekday, influenza epidemics, high pollen episodes, temperature (lag 0), relative 
humidity (lag 0 and 1–3d mean), and barometric pressure
Figure 8.  Percent change in emergency room visits for asthma among children, and for asthma-COPD 
among adults and the elderly for an interquartile change in traffic-related and long-range 
transported PM2.5 in 1998–2004 in Helsinki.
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6  DIsCUssIon
The current study compared the effects of air pollutants on cardiovascular and respiratory 
mortality and morbidity in the Helsinki metropolitan area, Finland. Respiratory health 
effects were stronger and more consistently observed than cardiovascular effects. All of 
the particle size fractions had some harmful health effects, accumulation mode particles 
and PM2.5 having most often adverse effects. Of the source-specified particles traffic-
related and long-range transported but also soil derived particles showed adverse health 
effects. It was also was found that children under 15 years of age and people aged ≥  65 are 
somewhat more sensitive to the effects of ambient air pollutants than adult population.
6.1  Cardiovascular versus respiratory health effects of 
ambient particulate pollutants
6.1.1  Morbidity: hospital admissions and emergency room visits
In the current study, it was shown that ambient air pollutants have harmful effects on 
respiratory health in Helsinki metropolitan area; however, there is less evidence about 
associations between pollutants and cardiovascular outcomes. One of the most significant 
findings of this study was the association between asthma exacerbation in children and 
traffic-related pollutants (article II, Figures 7 and 8). The associations for asthma visits with 
ultrafine particles, NO2 and PM2.5 from traffic were strong and consistently three to five 
days lagged. However, because these pollutants are closely correlated (Appendix Tables 
2 and 3), and the association of ultrafine particles became weaker and non-significant 
in two-pollutant model with NO2 (Table 6), we could not specify the causal component 
of traffic emissions that is responsible for the observed effect. Previously, traffic-related 
pollutants have been associated to health decrements in panel studies of asthmatic children 
in Kuopio (Pekkanen et al., 1997; Timonen and Pekkanen, 1997). In the APHEA study, 
asthma hospital admissions of children were heterogeneously associated with the levels of 
NO2, and in Helsinki asthma admissions were not affected by NO2 (Sunyer et al., 1997). 
However, the current study period was longer compared to APHEA study and therefore 
there was more power in the statistical analyses in the current study. The emergency room 
visit data used in this study may also be more sensitive than previously used hospital 
admission data, resulting in greater effect estimates. In general, our findings add to the 
cumulative evidence in support of the association between exposure to traffic-related air 
pollutants and respiratory health of children (Andersen et al., 2008; Andersen et al., 2007a; 
Barnett et al., 2005; Peel et al., 2005). 
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Among the elderly, respiratory morbidity was linked to increases in ozone and ambient 
particulate pollutants in different size fractions. Studying either hospital admission or 
emergency room visit data resulted in similar associations (articles II, III, and IV, Figures 4 
and 5). However, there were little associations between cardiovascular hospital admissions 
and ambient particles (article III). Greater effects on the respiratory than on cardiovascular 
health have been reported also by Anderson et al. (2001). In more recent studies, the 
effects on cardiovascular and respiratory health have been found comparable (Host et al., 
2008; Peng et al., 2008). 
In the current study, accumulation mode particles had a strong association with all 
respiratory diseases among the elderly, however, the same day effect was similar to that 
of PM2.5 (2.4%, 0.06–4.83, for 10 µg m
-3) and coarse particles (1.7%, –0.16–3.59 for 
10 µg m-3) (article III). The associations for accumulation mode or fine particles were 
independent of other pollutants, only minor changes in the effect estimates were observed 
after adjusting to co-pollutants (Table 6 and appendix of article III). Even though the 
levels of PM2.5 in Helsinki are low compared to other European cities and metropolises, 
as strong associations for respiratory diseases have rarely been reported elsewhere. In 
comparison, increases in all respiratory disease admissions in association with PM2.5 
among the elderly population have been 0.8% (95% CI –2.8–4.5, lag 0) in Canada (Fung 
et al., 2006), –0.7% (95% CI –2.4–1.1, 2-d mean) in the United Kingdom (Anderson et 
al., 2001), 0.0% (95% CI –9.8–10.8, 5-day mean) in Denmark (Andersen et al., 2008), and 
0.5% (95% CI –2.0–3.0, 2-d mean) in France (Host et al., 2008). However, in the study of 
Anderson et al. (2001) there was little evidence of any associations between air pollutants 
and morbidity, and the authors suggested that this was due to shortness of the time-series, 
or due to the small variance in the air pollution levels. In Denmark, on the other hand, 
the association had not been seen for PM2.5 but for accumulation mode particles and 
PM10. The association between accumulation mode particles and respiratory admissions 
of the elderly (4.0%, 95% CI 0.0–8.2 for 495 change in number count over 4-day mean) 
(Andersen et al., 2008) was similar to the current findings.
In the cause-specific analyses, accumulation mode particles and PM2.5 were more 
strongly associated with pooled asthma-COPD admissions than with all respiratory 
admissions among the elderly (article III). The association found between PM2.5 and COPD 
alone (9.2% (4.0–14.6), at lag 0) is comparable to those reported earlier from Detroit 
(Ito, 2003), and Vancouver (Chen et al., 2004). The associations between particles and 
respiratory health outcomes of the elderly were also stronger during the warm than during 
the cold season (article III). This may be due to the better exposure assessment during 
the warm season when people tend to be more active and spend more time outdoors. The 
ventilation through open windows is also more common in the summer than in winter, 
which leads to better exposure assessment to ambient particles. Greater warm season 
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(Medina-Ramon et al., 2006; Peng et al., 2005), but also cold season (Bell et al., 2008) 
effects of air pollution have been reported earlier. Differences between studies may reflect 
differences in particulate compositions, and in city specific characteristics such as climate 
(Medina-Ramon et al., 2006).
Cause-specific cardiovascular admissions had only weak associations with particulate 
pollutants, which were mainly due to arrhythmia cases. This finding is somewhat 
inconsistent with the evidence of cardiovascular effects of particulate pollutants reported 
previously from Helsinki (Lanki et al., 2006a; Pekkanen et al., 2002; Timonen et al., 2006; 
von Klot et al., 2005). The inconsistency between the current and previous morbidity 
studies may partly derive from different study populations included to the analyses. Earlier, 
a study by von Klot et al. (2005) included a cohort of people with a history of diagnosed 
cardiac event, and Pekkanen et al. (2002), Lanki et al. (2006a) and Timonen et al. (2006) 
studied a panel of patients with stable coronary heart disease. Therefore, it is possible 
that cardiovascular effects of ambient particles in Helsinki are seen only among the more 
susceptible individuals, such as those with some underlying cardiorespiratory disease.
6.1.2 Mortality
All respiratory and pneumonia mortality of the elderly were also associated with particulate 
air pollution (article III). A significant association was observed between all respiratory 
mortality and accumulation mode particles (5.06% / IQR 287, at lag 1) the fraction 
that is closely correlated with PM2.5. Even though no earlier studies have determined 
the associations between respiratory mortality and size-specified particles, respiratory 
mortality of the elderly has correspondingly been linked to changes in ambient PM2.5 
(Franklin et al., 2007; Goldberg et al., 2001b). In Helsinki, inhalable particles, PM10, have 
also been linked to increased respiratory mortality in the total population (Penttinen et al., 
2004). 
The associations between cardiovascular mortality and ambient particulate matter or 
ozone were again weaker than associations observed for respiratory mortality (articles 
III and IV). Conclusions that support this finding for particles have been reported in two 
earlier studies (Pope et al., 1992; Wichmann et al., 2000). However, recently a finding 
where the effects of particles on cardiovascular health were stronger than on respiratory 
health was also reported (Ostro et al., 2007). 
In the current study, all cardiovascular mortality among the elderly had a positive 
association with the current-day PM2.5 only during the warm season. This association 
was explained in the cause-specific analyses by stroke mortality (article I). However, 
because there was also a negative association between stroke hospital admissions and 
PM2.5 (Figure 3, article III), the usability and comparability of the mortality and hospital 
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admission registers for stroke is discussed in more detail in the section 6.1.3.
Particulate air pollution has been associated with cardiovascular health decrements 
in numerous epidemiological studies worldwide (Table 1). The approximate increase 
in cardiovascular mortality in association with 10 µg m-3 increase in PM2.5 has been 
estimated to be 1% (Pope and Dockery, 2006). Such an association was not observed in 
Helsinki. The reasons for the inconsistent findings from the current study compared to the 
majority of previous literature are difficult to determine. One explanation can be that the 
composition of fine particles in Helsinki differs from that elsewhere in Europe or in North 
America. Long-range transported particles account for about half of the fine particle mass 
in Helsinki (Kulmala, 2000; Vallius et al., 2003), and during the transportation, particles 
may go through chemical reactions in the atmosphere that possibly convert them into 
less toxic forms. Thus it can be speculated that the irritating and inflammatory effects of 
particles would explain the observed respiratory effects, even if the particles were less 
toxic, but they would not be strong enough to affect the cardiovascular system. There is 
already some evidence that the local differences in the health effects are due to different 
particle components (Bell et al., 2009), however, there are no studies that would have shown 
that more toxic particles are required for the cardiovascular than for respiratory effects. 
Other reasons could be the smaller variation in the particulate levels, and somewhat worse 
exposure assessment to ambient pollutants in Helsinki compared to warmer countries and 
cities. In Finland, ventilation through windows is uncommon during long and cold winters, 
and houses in general are built tight, which decreases the exposure to ambient particles. 
During the cold season the impact of indoor sources on personal exposure may also be 
higher (Brown et al., 2008). The worse exposure assessment would affect especially the 
whole year and cold season effect estimates, which is supported by the current findings 
where stronger associations for the respiratory outcomes were observed for the warm 
season analyses compared to whole year analyses (article III).
6.1.3 Comparison between morbidity and mortality analyses
In this study, data on daily mortality, hospital admission, or emergency room visit counts 
were used. Most of the analyses were performed for only one or two data bases, because of 
the lack of data (emergency room visit data available only for asthma and COPD), or the 
low number of cases (e.g. mortality among adults and children). For those outcomes where 
analyses were run for different data bases, the main conclusions from the analyses were 
mainly the same. However, for some endpoints, especially stroke, also clear differences 
were observed, as discussed below.
For all respiratory causes, conclusions on associations with mortality and hospital 
admissions were similar in the sense that for both outcomes a significant association with 
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accumulation mode particles and with PM2.5 was found on the current day (article III). For 
all respiratory admissions, significant associations were found for several lag days, but for 
mortality only the association at lag 0 was significant. This difference between mortality 
and morbidity analyses may be due to the fact that more severe exacerbation of disease is 
needed for a death than an admission to take place. Because the proportion of population 
that suffers from respiratory outcomes leading to admissions is larger than the population 
suffering from mortality, the more severe outcome (Figure 1), admission analyses have 
more statistical power, which is likely to lead to more significant associations.
Analyses for all three data bases (mortality, hospital admission, and emergency room 
visit) were only performed for asthma-COPD among the elderly. However, in the mortality 
analyses only deaths for COPD were included. Here again mortality and morbidity 
analyses showed similar positive associations with PM2.5 and accumulation mode 
particles at lag days 0–1 (Figure 4, articles II and III). The strongest associations were 
found for asthma-COPD emergency room visits (article II), and the weakest associations 
for COPD mortality (article III). It seems that emergency room visit data is more sensitive 
to describe changes in morbidity than hospital admission data. This is possibly because 
the emergency room visit data includes all acute asthma-COPD event seeking emergency 
care, also the less severe ones, but to be counted as an admission the subject needs to stay 
in hospital over night. In addition, patients presenting late in the evening are more likely to 
stay overnight in the hospital, although the severity of their attack may be comparable to a 
patient presenting early in the morning and leaving on the same day. The lower number of 
COPD deaths compared to exacerbations may again have resulted in weaker associations 
in the mortality analyses. It therefore seems that emergency room visit data describes 
better the associations of ambient pollutants with acute exacerbation of asthma and COPD 
than hospital admissions or mortality and should be favored in the future studies. 
In both, mortality and hospital admission analyses for pneumonia among the elderly, 
associations with accumulation mode particles and PM2.5 were found (article III). 
However, a difference in the associations was that for mortality significant association 
was found on the same day, whereas for admissions significant associations were found 
at lag day 1 and over the 5-d mean. The difference in the effect lag may be explained 
by the behavioral reasons. People may wait at home a day or two for the disease to get 
more severe before seeking medical help from hospitals, which is why the associations for 
pneumonia admissions occur at later lags than associations with mortality.
Mortality and morbidity data bases for all cardiovascular diseases and coronary heart 
disease among the elderly were consistent in the sense that both data sets provided mainly 
small effect estimates that were not significant (article III). 
The largest inconsistency between mortality and morbidity analyses was found for 
stroke, where mortality was positively (article I) and morbidity negatively associated with 
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PM2.5 (Figure 3 and article III). The negative association between stroke admissions and 
PM2.5 is consistent with the results of a Taiwanese study (Chan et al., 2006). However, we 
do not know what the reason for the negative association is, or whether it is an association 
found by chance. It seems valid to suggest that elderly patients who have suffered from 
stroke form a vulnerable population group that may then suffer from pneumonia and 
other diseases ending in hospitalization and finally in death. Thus the diagnosis for the 
hospitalization (and immediate cause of death) may be registered as something else than 
stroke, but the underlying cause of death, used in the current mortality analyses, in the 
register may be stroke. Therefore there is possibly some overlap in the data used for stroke 
mortality and for stroke hospital admissions and the current results for mortality and 
admissions are not fully comparable. Future studies should combine fatal and non-fatal 
strokes on an individual level to provide more information about the mechanism of action 
of particulate matter on stroke. 
In the present study, it was possible to use an exceptionally wide array of registers and 
outcomes. The study showed that using different registers and several disease outcomes 
in the same study is useful, and it provides a wider perspective on the health effects of 
ambient pollutants. Although mostly, the results from analyses using different registers 
gave similar conclusions on the acute health effects of ambient pollution, also some 
severe differences were observed, mainly for stroke. Therefore, before embarking on new 
register-based time series studies, the investigators should carefully scrutinize the validity 
of the register data to be used in the light of the hypothesis to be tested. When possible, 
like in the Nordic countries, several registers should be combined to get a more complete, 
non-overlapping data on mortality and morbidity. 
6.2  Role of particle size fractions and PM2.5 sources
The source apportionment of PM2.5 via positive matrix factorization analysis in the current 
study provided information on the same sources as earlier principal component analysis 
performed for Helsinki PM2.5 data (Vallius et al., 2005; Vallius et al., 2003). Only sea salt 
could not be separated as its own factor because of the lack of suitable marker elements. 
However, the average source contributions were in the range of earlier results (Vallius et 
al., 2005; Vallius et al., 2003). Due to the long time period (2 557 days) the model was 
stable and therefore considered valid for the apportionment of sources. The method has 
also been found to be comparable with other source apportionment methods (Thurston et 
al., 2005). 
Traffic-related PM2.5 and ultrafine particles, a marker of traffic-related particles, were 
now investigated in separate models. Stronger associations were observed for asthma 
exacerbation among children with ultrafine particles (6.3% / IQR (5 700) increase in UFP 
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over the 5-d mean) than with larger particles, and with traffic-related PM2.5 than PM2.5 
from other sources (article II). The associations for traffic-related pollutants at lags 4 and 5 
were also statistically different from the associations at lag 0. This suggests that fresh local 
particles among other traffic emissions are harmful especially for the respiratory system of 
children and that the response among children is not acute. However, because the effect of 
ultrafine particles was very similar to those of NO2 and CO, and because the association for 
ultrafine particles was changed in two-pollutant model with NO2 (Table 6), these results 
suggest that it is the mixture of traffic-related pollutants causing the effects. The strong 
effect of NO2 on asthma visits of children suggests that especially NO2 is a good marker of 
traffic-related emissions, which is consistent with previous findings (WHO, 2005). Only 
two other studies have investigated associations between asthma and ultrafine particles 
in a time-series setting. Andersen et al. (2008) reported very identical findings compared 
to the current results. Peel et al. (2005) studied also the effects of ultrafine particles on 
asthma emergency room visits. The results were in agreement with the current findings: 
associations were stronger among children than among adults, and the strongest effects 
were observed to be 5 to 8 days delayed. However, this study had incomplete data of 
ultrafine particles with 44% days of missing data. In several other studies, particles related 
to traffic have also been suggested to be the most harmful for health (Gold et al., 2005; 
Laden et al., 2000; Metzger et al., 2004; Ostro et al., 2007; Sarnat et al., 2008).
For the other health outcomes and age groups, however, the difference between the 
effects of different particle fractions or PM2.5 sources was not that clear. Exacerbation of 
all respiratory diseases, pneumonia, and asthma-COPD among the elderly, and asthma-
COPD among adults were associated with several particulate fractions and sources 
(articles II and III, Figures 4 and 6). In many previous studies black smoke or black carbon 
have been shown to have strong effects on health outcomes (Analitis et al., 2006; Bremner 
et al., 1999; Schwartz et al., 2005). These pollution measures are markers of carbon 
containing particles that are emitted from various combustion sources. As we were lacking 
the elemental data of the particles for our source apportionment analysis, we could not 
separate the causal components of particles. This means that harmful particle components 
such as elemental carbon are possibly included in several, if not in all, source categories 
determined in this study, and therefore adverse effects are seen in more than one source 
category. 
All the associations found among older age groups were the strongest at lags 0 to 2 
days (articles II and III) and therefore different from those found among children (article 
II). However, even though the effects seem acute, there is also some cumulative effect of 
particles among the elderly as the effect estimates for some of the particle measures over 
the 5-day mean were higher than those for the individual lags (article III). 
The strongest associations among the elderly were observed between respiratory 
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morbidity and accumulation mode particles that mainly originate from long-range transport 
(articles II and III). Similar associations have been reported earlier by Penttinen et al. 
(2006) and Andersen et al. (2008). Peters et al. (1997) have also suggested that particles in 
both ultrafine and accumulation mode size fractions have effects on the respiratory health 
among asthmatic adults. Accumulation mode particles are mostly secondary particles, 
which have also been linked to increased respiratory and cardiovascular morbidity 
elsewhere (Sarnat et al., 2008). 
The lack of clear and independent associations between particles in the ultrafine size 
fraction and health outcomes, and stronger associations found for PM2.5 and accumulation 
mode can be a result of differences in the exposure assessment. Exposure assessment of 
ultrafine particles is poorer compared to fine particles. This is due to the local variation 
in ultrafine particle concentrations, and the poor penetration ability of these particles to 
indoor environments (Koponen, 2001). As people, especially adults and the elderly, spend 
most of their time indoors they may actually be rarely exposed to fresh ultrafine particles. 
It is possible that the individual effects of ultrafine particles are difficult determined in 
population level studies where central site measurements are used as proxies to personal 
exposure.
Even though clear differences between the effects of particle sources were not found 
in this study, it seems that traffic is one of the most harmful emission sources of ambient 
pollutants in Helsinki, and also elsewhere (Gold et al., 2005; Laden et al., 2000; Metzger et 
al., 2004; Ostro et al., 2007; Sarnat et al., 2008). It cannot be differentiated however, based 
on these results, which of the individual traffic-related pollutants is responsible for the 
health effects in Helsinki. This is partly due to the current lack of particulate component 
data. It is supposed that it is the mixture of pollutants, rather than a single pollutant 
that causes the observed health effects in the airways. Part of this mixture, contributing 
especially to the mass of fine particles, is also formed of non-exhaust particles derived 
from car brakes, traffic road abrasion, and re-suspended road dust (Thorpe and Harrison, 
2008), and the possible health effects of the non-exhaust particles have not been evaluated 
so far. However, traffic exhaust pollutants are those whose emissions are being regulated, 
and we can try to avoid exposure to them. The portion of long-range transported particles 
in Helsinki, on the other hand, cannot be regulated or limited only by local actions. 
Therefore, to avoid the health effects of these particles, the international vehicle emission 
restrictions such as Euro 5 and 6 (The EEA Joint Committee, 2007) should be fulfilled 
also in other European countries and in Russia from where the particles are transported 
to Finland. 
The Euro 5 and 6 standards are one of the measures designed to reduce emissions 
of particulate matter and ozone precursors such as nitrogen oxides and hydrocarbons. 
These standards are based on the findings of health risks reported in the CAFÉ Programme 
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(European Union, 2005). The standards are needed, but it takes tens of years to regenerate 
the whole car pool that is currently in use. Because the reductions of the traffic-related 
emissions via new technologies slowly improve the air quality, we should now pay 
attention to the exposure patterns of traffic-related air pollutants.  
6.3 Does age matter?
There were clear differences between the effects of ambient particles on asthma and 
COPD emergency room visits found among children and older people. Among the elderly 
and adults the associations were observed for accumulation mode particles, PM2.5, and 
coarse particles at lag days 0 to 2 (Figure 4, articles II and III), but among children there 
were associations with traffic emissions, including ultrafine particles, with 3 to 5 days 
delay (Figure 6 and article II). At lag 4, the effect of traffic-related pollutants on the 
asthma visits among children was statistically significantly different from adults and the 
elderly (article II). The reason for the different lag structures can be due to different effect 
mechanisms between different particle fractions; ultrafine particles can penetrate deeper 
into the lung than fine particles (Donaldson and Stone, 2003), and their clearance from the 
airways is slower than that of larger particles (Kreyling et al., 2006). Therefore, ultrafine 
particles may cause inflammation in the lower airways and lung tissues, and time from the 
induction of inflammation cascade to the actual observable effect may be longer. Larger 
particles, however, deposit mainly on the upper region of the respiratory system (Schulz, 
2000) and may cause irritation and epithelial disruptions that might induce exacerbation 
of respiratory illnesses with shorter delay. 
The size of the harmful particle fraction also differed between age groups. Ultrafine 
particles, with other traffic-related pollutants, had stronger associations than larger particles 
among children (Figure 6, article II) whereas larger particles; accumulation mode particles, 
PM2.5, and coarse particles had more associations among the elderly (Figure 4, article II). 
This difference between age groups can be related to the differences in the exposure and in 
the exposure assessment of pollutants, which derives from different time activity patterns 
between children and older people. Children are active and known to spend more time 
outdoors than adults (Klepeis et al., 2001; Liu et al., 2003), and therefore they presumably 
get also more exposed to short-lived ultrafine particles and other traffic emissions. Adults 
may more often work in air conditioned office buildings than other population groups, 
which diminishes their exposure to ambient pollutants, and especially the exposure to 
ultrafine particles (Koponen, 2001). Healthy adults may also be biologically the least 
sensitive group to the effects of air pollution. Their respiratory system is fully developed 
and they are not yet suffering from chronic diseases or other reductions in the defense 
mechanisms in the airways as the elderly often do.
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6.4 Acute health effects of ambient ozone
In addition to particulate pollutants, asthma among children and asthma-COPD among 
the elderly were exacerbated after exposure to ozone during the warm season (article IV 
and Figure 5). The association between ozone and respiratory outcomes seemed to be 
independent of PM2.5 (Figure 5) and even stronger than that of PM2.5, which could derive 
from the high oxidative capacity of ozone. Associations between ozone and respiratory 
morbidity have been reported also in numerous epidemiological studies elsewhere (Babin 
et al., 2007; Ko et al., 2007; Medina-Ramon et al., 2006; Moore et al., 2008; Spix et al., 
1998; Szyszkowicz, 2008). 
Even though the association between ozone and mortality has been well established 
in several multi-city studies from Europe, North America, and Asia (Bell et al., 2005; 
Gryparis et al., 2004; Ito et al., 2005; Levy et al., 2005; Wong et al., 2008), and once 
in Helsinki (Penttinen et al., 2004), such associations were not observed in the current 
analyses. There was a positive association between ozone and cardiovascular mortality 
among adults when the model was adjusted for PM2.5. However, the association with 
ozone was not significant in the single-pollutant model (article IV). Adjusting for PM2.5 
affected also the association observed between ozone and arrhythmia admissions among 
the elderly. After adjusting the model for PM2.5, the effect estimate for ozone was smaller 
than in single-pollutant model, and non-significant (article IV). It is possible that some 
confounding occurs between O3 and PM2.5 in Helsinki, because much of both pollutants is 
long-range transported. In line with this is the suggestion that O3 would be a surrogate for 
secondary particles or PM2.5 exposure (Sarnat et al., 2001). 
There was also a negative association between ozone and cardiovascular mortality 
among the elderly. There is no clear explanation for this, but it can be speculated that 
on hot days, when ozone concentrations are high, the elderly people stay indoors and 
therefore they are less exposed to ambient pollutants, and the effect turns to negative.
The levels of ozone in Helsinki exceed the air quality guideline level (100 µg m-3, 8-hour 
mean) set by WHO (WHO, 2005) few times each year, and the mean levels of ozone have 
been slowly increasing, rather than decreasing, during the last decade. It is noteworthy 
that the health effects were observed already at the current levels, because ozone levels are 
expected to increase in the future because of the global warming (Patz et al., 2005). Warmer 
climate may accelerate ozone formation and therefore increase the ambient levels of this 
pollutant. Local formation of ozone in Helsinki may also increase. This is partly because 
of the increasing trend of using diesel-driven cars with the current technology that leads to 
larger emissions of ozone precursor gases such as NO2 than emissions from petrol-driven 
cars. At the same time, there is a decreasing trend in the levels of traffic-related particles 
and thus there are less ozone sinks i.e. pollutants consuming ozone. Overall, limiting the 
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vehicle emissions is a double-edged sword because the reduction of emissions of particles 
and emissions of ozone precursor gases are difficult to be implemented at once.
6.5 Validity considerations
The data measurements of this study were carefully performed, and the measurement period 
of ultrafine particles was longer than in previous studies (Peel et al., 2005; Wichmann et al., 
2000). It is also unique that ambient particles were continuously measured in several size 
fractions making it possible to study different particle fractions separately. The health data 
in this study was also of good quality. The data for this study was derived from national 
registers where all diseases were coded by the International Causes of Diseases 10th 
revision codes. National Causes of Death Register in Finland has been maintained since 
the 1969. The current form of National Hospital Discharge Register has been maintained 
since 1987, but similar, though not as accurate, information has been collected already 
from the 1969. Validity of the National Causes of Death and Hospital Discharge Registers 
in Finland has been shown to be good at least for stroke (Tolonen et al., 2007), coronary 
heart disease (Pajunen et al., 2005), and myocardial infarction (Rapola et al., 1997). Even 
though the data quality of this study is good and the methods used are commonly accepted, 
there are some weaknesses in this study that are discussed below.
In environmental epidemiology, the problem of possible confounding by several 
environmental variables is always present. In this study, the effects of weather variables 
were controlled by the models used. Confounding of ambient co-pollutants is also possible, 
and therefore some two-pollutant models were run in this study. It was found that NO2 
has some confounding effect on the associations of particulate pollutants, especially on 
the associations of ultrafine particles (Table 6 and article III). However, because the levels 
of NO2 and CO in Helsinki are low, these are considered more of markers of their source, 
which is mainly traffic, rather than causal pollutants. Because NO2 seemed to confound 
the association of ultrafine particles, and because there is lack of biological plausibility 
for the effects of gaseous pollutants, it is difficult to determine the causal pollutant that is 
responsible for the observed effects among children. Some confounding was also observed 
between ozone and PM2.5 (article IV). When adjusting the ozone model to PM2.5, the 
association between ozone and cardiovascular mortality among adults became stronger, 
but the association between ozone and arrhythmia admissions of the elderly became 
weaker (article IV). However, the 2-pollutant models may not be able to separate the 
effects of individual pollutants because of the correlations of pollutants originating from 
the same source, and findings that some pollutants are acting as surrogates for personal 
exposure to fine particles from mobile sources (Sarnat et al, 2001). 
One possible limitation of the study is the validity of the exposure assessment. Exposure 
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assessment to ambient pollutants would be best evaluated with personal monitoring of 
pollutants. However, this would show the true exposure only if the ambient and non-
ambient origin particles were also separated. Personal measurements are not possible 
for population level studies such as time-series studies because of their high costs, and 
therefore measurement campaigns have been performed to evaluate the usability of central 
site measurements as proxies to personal exposure in the study area. Because most of the 
fine particle mass in Helsinki is long-range transported (Kulmala et al., 2001; Vallius et 
al., 2003), the concentrations are not too heavily affected by the local particle sources. 
It has been shown that the central site measurements for PM2.5 are valid to be used as 
proxies for personal exposure in epidemiological studies (Pekkanen and Kulmala, 2004). 
Indoor and outdoor concentrations of PM2.5 are also highly correlated in Helsinki (Hoek 
et al., 2008; Janssen et al., 2005), which indicates that the variation in personal exposure 
to these particles is comparable to the measured variation in ambient levels. However, 
the correlations between indoor-outdoor concentrations of particle number and PM10 are 
lower (Hoek et al., 2008). The correlation between ultrafine particle counts at different 
outdoor measurement sites in Helsinki has been found to be moderate (Aalto et al., 2005; 
Buzorius et al., 1999; Hussein et al., 2004b). 
A possible source of exposure misclassification in this study may also be the time 
lag used. The air pollutants were measured from midnight to midnight, and the death 
and morbidity counts were daily. Thus if the event occurred at 1 a.m., for example, it is 
not lag 0, but lag 1 that describes the exposure 24-hours preceding the event. Because 
we analyzed several lag days, it is reasonable to assume that none of the effects was 
missed. However, we did not have the times of deaths, admissions or emergency room 
visits for more accurate grouping of exposure, which possibly leads to some random 
misclassification and attenuation the observed effects. 
Data collection for this study was performed over the years 1998–2004. The particulate 
and gaseous pollutant measurements were available for the whole study period. However, 
the locations of particulate mass and particle number count measurement sites changed 
once during the study period. The measurement site change was taken into account in the 
statistical analyses so that it would not affect the results. 
In this research, an extensive number of statistical analyses were performed using a 
variety of air pollutant measures, health outcomes, several time lags, and three different 
age groups. All this testing may have led to some significant effects that were due to 
chance. Therefore more focus is put on those findings where the effects are consistent. 
This means that there is a trend in the effect lag structure showing a biologically plausible 
effect, and that the effect is similar over several related exposures and outcomes.
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6.6 Suggestions for future studies
This study had an extensive data, and numerous analyses were performed, but there is still 
need for further studies. There was a lack of the elemental data on the particle compositions 
in the current study, which is why the portion of sea salt in the PM2.5 mass could not be 
separated like it had been done in the previous study by Vallius et al. (2003). For the same 
reason, the mass of non-exhaust traffic particles, or particles that are derived from biomass 
combustion could neither be apportioned. To apportion the particles from the biomass 
combustion there should have been measurements of markers of wood combustion such 
as levoglucosan (Simoneit et al., 1999). Apportionment of particle sources with data 
including elemental particle composition could also better reveal differences between the 
health effects by particle sources.
There is increasing interest in studying the health effects of particles from biomass 
combustion. For example, in a recent animal study, particles from wood combustion 
were shown to have an almost equal allergy adjuvant effect than particles from traffic 
sources (Samuelsen et al., 2008), and a chamber study showed that exposure to wood 
smoke increases the levels of airway inflammation markers (Barregard et al., 2008). 
In Helsinki metropolitan area, wood is used as a secondary heat source in 58% of the 
residences (Haaparanta et al., 2003), and therefore the use of fireplaces probably produces 
a considerable portion of the ambient fine particle mass especially during the cold season. 
However, little is known about the health effects of the particles from wood and biomass 
combustion, and more research on the particle sources generally is still needed to specify 
more clearly the most harmful particles.
Little associations were observed for cardiovascular outcomes in this study and one of 
the suggested reasons was that the components of particles in Helsinki are different from 
other studies. A measurement campaign that would enable determination of the components 
of particulate matter would make possible the comparison of the PM component data in 
Helsinki to data from other cities. This could provide evidence for the hypothesis that there 
are differences in the particulate compositions between study locations. Additionally, the 
health effects on cardiovascular outcomes could be more precisely studied in analyses by 
particulate components.
In the current study, the individual effect of ultrafine particles could not be shown, but 
their effect was related to traffic emissions as a whole. To further study the role of specified 
particle fractions or individual pollutants, panel and chamber studies are needed. In panel 
studies, there is possibility to assess personal exposure more accurately than in time-series 
studies, which makes the analyses more reliable. If different pollutants can be personally 
monitored at the same, the confounding effects of co-pollutants could also be addressed. So 
far, there are only a few panel studies determining the effects of ultrafine particles (Ruckerl 
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et al., 2006). In chamber studies, exposure to pollutants could be controlled for, and exposure 
to a specified pollutant could be studied (Samet et al., 2007). This way the exclusion of the 
possible confounding effects of co-pollutants would also be possible. However, there are 
some limitations when considering these study methods. In both cases, there can be only 
small number of cases included, and the costs are high. Moreover, in the chamber studies 
one can only study health subjects and health outcomes that are reversible.
We do not know how much the validity of exposure assessment actually differs between 
age groups. Therefore there remains also need for panel studies measuring and comparing 
personal exposure among children, adults, and the elderly. Personal measurements and 
time-activity diaries could provide evidence for the argument that the negative association 
observed between cardiovascular mortality and ozone during the warm season is really 
due to the habit of elderly staying indoors on hot days therefore exposing less to ambient 
pollutants. Another way to study why this negative effect was found could be stratification 
of the data by temperature instead of season.
It is possible that using the 24-hour average concentrations for the pollutants in time-
series studies masks the possible effects of shorter exposure peaks. Studies using shorter 
time scale for the pollutant measurements, and health data including the time of onset of 
the health outcome could be able to reveal such short-term associations.
As we were not able to link mortality and morbidity data on an individual level, some 
overlap between the data sets occurs in the current study. The linkage between the two data 
would make the separate determination of the effects of air pollutants on in- and out-of-
hospital mortality possible (Forastiere et al., 2005).
In this study, three sub-populations were studied to find out the vulnerable age 
groups. To further explore possibly vulnerable sub-populations, medical history of sub-
populations could be used. Diabetics and asthmatics, for example, have been suggested 
to be more vulnerable to the effects of air pollution (Sarnat and Holguin, 2007; Zanobetti 
and Schwartz, 2001). Another way to determine susceptible population groups is the study 
of gene-environment interactions. Studies where blood samples are drawn from the study 
subjects such as cohort or panel studies, could exploit the available technologies to assess 
the differences in the human genome. Then also the associations between polymorphism 
and environmental stressors could be studied. A number of important gene-environment 
interactions have already been identified, and the interactions suggest that the involved 
genetic variation is suggestive of certain underlying effect mechanisms (von Mutius, 
2009).
Finally, the health effects studied here were short-term effects. Following a cohort 
of people from Helsinki would make it possible to study the health effects of long-term 
exposure to air pollutants. So far no Finnish cohorts have studied the health effects of air 
pollution.
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7 ConCLUsIons
The main conclusions from this study are In Helsinki, there are consistent associations 
between ambient air pollutants and respiratory health, but there is less evidence about 
the association between air pollutants and cardiovascular health. Previous international 
studies and panel studies from Helsinki suggest the importance of particulate matter in 
Helsinki, but the cardiovascular effects are possibly seen only among more vulnerable 
population groups such those with an underlying cardiorespiratory disease.
There are some differences in the health effects of ambient particles in different size 
fractions. Particles in the accumulation mode (0.1–0.3 µm) that very well describe the 
mass of particles with diameter  < 2.5 µm have more associations with different respiratory 
outcomes than other particle fractions, especially among the elderly. These associations 
are 0–2 days lagged. Ultrafine particles (< 0.1 µm), among other markers of traffic, have 
more delayed association with the exacerbation of asthma among children. However, 
in this study it was not possible to identify the causal component of traffic emissions 
responsible for the observed effects. Among older age groups investigated, the poorer 
exposure assessment of ultrafine particles may have caused the lack of such associations. 
Traffic-related particles seem to cause stronger health effects than particles from 
other sources among children. Among the elderly and adults, particles from traffic and 
long-range transport, but also from soil are harmful. The difficulty to separate the effects 
between sources may be due to the distribution of the causal components of ambient 
particles to different source fractions, e.g. the harmful carbon components can be found in 
both the traffic and long-range transported particles. The particle components could not be 
determined from the data in use.
The effects of particulate pollutants on respiratory health are greater among children 
and the elderly than among adults. This may be a result of the greater vulnerability of 
children because of the developmental stage of their respiratory system, and the greater 
amount of inhalation compared to their body mass than among older people. Vulnerability 
of the elderly may derive from biologically decreased pulmonary function or other 
underlying diseases. Another reason for the differences between age groups can be the 
exposure patterns with children probably experiencing the most exposure especially to 
ultrafine particles and other traffic-related pollutants.
Among children, ozone and traffic-related pollutants, including ultrafine particles, 
have a strong effect on asthma exacerbation. Reductions in the exposure to traffic-related 
pollutants that are also precursors of ozone, should be aimed mainly by reducing emissions 
through city planning, increased use of public transport, and by improved engine design. In 
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addition, to decrease the health effects of these pollutants we should diminish the exposure 
to them by avoiding outdoor activities near heavy trafficked roads. In the town planning, 
the location of day care centers, schools, and nursing homes should not be in the vicinity 
of highly trafficked roads. In those buildings in close vicinity to roads, the air filtration 
should be well arranged.
Among the elderly, ozone and particles in different size fractions have detrimental 
effects on respiratory health. The effects are seen especially as exacerbation of asthma-
COPD and pneumonia. The harmful particles are mainly derived from long-range transport, 
soil and traffic. Therefore the reduction of ambient air pollutant emissions not only locally, 
but also globally would be necessary. 
The results underline the importance of particulate matter together with ozone as a 
main environmental threat to health also in Helsinki.
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APPenDICes
Appendix Table 1. Summary of particulate mass and gaseous pollutant concentrations, and number 
counts of particles by season in, 1998–2004 in Helsinki. 
Nucleation mode (< 0.03 µm) (1 cm-3) Min 25% Mean 75% Max Sd
Whole year 379 2673 4859 6256 22790 3168
Warm season 412 2215 3682 4844 12970 1916
Cold season 379 3162 5701 7324 22790 3591
Aitken mode (0.03–0.1 µm) (1 cm-3)
Whole year 400 2470 4000 4937 27990 2264
Warm season 570 2734 3936 4796 11820 1695
Cold season 400 2286 4045 5017 27990 2596
Ultrafine particles (< 0.1 µm) (1 cm-3)
Whole year 914 5780 9273 11540 50990 5137
Warm season 1819 5616 8068 10000 21340 3344
Cold season 914 5989 10130 12830 50990 5958
Accumulation mode (0.1–0.29 µm) (1cm-3)
Whole year 57 238 417 525 2680 260
Warm season 68 244 423 549 1839 242
Cold season 57 235 412 512 2680 272
PM2.5 (µg m-3)
Whole year 1.1 5.5 9.5 11.7 69.5 5.9
Warm season 1.1 5.3 8.8 11.0 41.5 5.0
Cold season 1.1 5.6 9.9 12.3 69.5 6.4
Coarse PM, PM10–2.5 (µg m-3)
Whole year 0.0 4.9 9.9 12.1 101.4 8.3
Warm season 0.0 6.1 9.5 11.8 42.0 5.1
Cold season 0.0 4.2 10.2 12.5 101.4 9.9
O3 (µg m-3 8-hour max moving average)
Whole year 1.6 49.6 63.0 76.6 159.1 20.0
Warm season 16.3 58.6 71.3 84.1 159.1 17.9
Cold season 1.6 44.0 57.1 68.8 130.6 19.4
NO2 (µg m-3)
Whole year 3.4 20.1 28.2 34.3 96.4 11.3
Warm season 3.4 19.3 26.5 32.7 66.8 10.0
Cold season 5.9 20.9 29.4 35.5 96.4 12.1
CO (mg m-3 8-hour max moving average)
Whole year 0.1 0.3 0.5 0.6 2.4 0.22
Warm season 0.1 0.3 0.4 0.5 1.1 0.16
Cold season 0.1 0.4 0.5 0.6 2.4 0.25
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Appendix Table 2. Spearman rank correlations between air pollutants and environmental factors during the warm season in 1998–2004 in Helsinki.
NUC AIT ACC PM25 PMC TRAF LRT SOIL COAL NO2 O3 CO TEMP RH Bp
UFP 0.89 0.89 0.30 0.29 0.47 0.74 0.04 0.46 0.37 0.59 0.09 0.39 –0.15 –0.17 0.15
NUC 0.60 0.04 0.04 0.36 0.68 –0.17 0.34 0.16 0.43 –0.07 0.37 –0.30 –0.21 0.10
AIT 0.46 0.43 0.47 0.66 0.21 0.46 0.50 0.62 0.20 0.33 0.01 –0.07 0.15
ACC 0.90 0.38 0.18 0.76 0.43 0.34 0.47 0.45 0.18 0.49 0.17 0.08
PM25 0.40 0.19 0.81 0.46 0.30 0.47 0.43 0.23 0.43 0.17 0.10
PMC 0.28 0.25 0.99 0.36 0.47 0.38 0.21 0.02 –0.33 0.24
TRAF –0.08 0.29 0.04 0.54 –0.06 0.68 –0.11 0.01 0.06
SEC 0.25 0.21 0.25 0.42 0.08 0.38 0.30 –0.02
SOIL 0.33 0.49 0.40 0.21 0.07 –0.33 0.26
COAL 0.52 0.20 0.03 0.02 –0.14 0.21
NO2 0.08 0.36 0.03 –0.02 0.20
O3 –0.06 0.28 –0.34 0.09
CO 0.01 0.13 0.05
TEMP 0.02 0.08
RH –0.40
Nuc = nucleation mode particles, diameter < 0.03m, Ait = Aitken mode, 0.03–0.1m, Accu = Accumulation mode, 0.1–0.29 µm, PMC = coarse PM, PM10-2.5, Traf = Traffic PM2.5,  
LRT = Long range transported PM2.5, Soil = Soil PM2.5, Coal = Coal and oil combustion PM2.5, Temp = Temperature, RH = Relative humidity, Bp = Barometric pressure
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Appendix Table 3.  Spearman rank correlations between air pollutants and environmental factors during the cold season in 1998–2004 in Helsinki.
NUC AIT ACC PM25 PMC TRAF SEC SOIL COAL NO2 O3 CO TEMP RH Bp
UFP 0.94 0.91 0.40 0.37 0.18 0.75 0.15 0.15 0.46 0.67 –0.09 0.47 –0.30 –0.13 0.11
NUC 0.74 0.20 0.19 0.12 0.66 0.01 0.10 0.33 0.58 –0.08 0.40 –0.35 –0.16 0.07
AIT 0.58 0.52 0.20 0.76 0.30 0.17 0.56 0.69 –0.11 0.49 –0.19 –0.05 0.16
ACC 0.87 0.11 0.32 0.79 0.11 0.45 0.33 –0.12 0.30 0.05 0.16 0.14
PM25 0.19 0.22 0.83 0.20 0.52 0.33 –0.01 0.31 –0.09 –0.02 0.20
PMC 0.12 –0.01 0.99 0.13 0.26 0.32 0.06 0.19 –0.51 0.22
TRAF –0.05 0.11 0.19 0.68 –0.21 0.66 –0.06 0.04 0.08
SEC –0.03 0.38 0.08 –0.01 0.14 –0.06 0.16 0.11
SOIL 0.10 0.26 0.32 0.05 0.20 –0.51 0.22
COAL 0.48 –0.11 0.24 –0.37 –0.13 0.22
NO2 –0.11 0.47 –0.20 –0.07 0.20
O3 –0.24 0.11 –0.50 0.01
CO –0.12 0.07 0.03
TEMP 0.05 –0.03
RH –0.28
Nuc = nucleation mode particles, diameter < 0.03m, Ait = Aitken mode, 0.03–0.1m, Accu = Accumulation mode, 0.1–0.29 µm, PMC = coarse PM, PM10-2.5, Traf = Traffic PM2.5,  
LRT = Long range transported PM2.5, Soil = Soil PM2.5, Coal = Coal and oil combustion PM2.5, Temp = Temperature, RH = Relative humidity, Bp = Barometric pressure Appendix 
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Appendix Table 4. The average percent contributions of the identified sources to PM2.5 mass, and 
concentrations of source-specified PM2.5 by season in, 1998–2004 in Helsinki. 
PM2.5 Source (µg m-3) % of PM2.5 Min 25% 50% 75% Max
Long-range transport 57
Whole year 0 2.5 5.5 7.3 30.8
Warm season 0 2.2 4.8 6.4 20.7
Cold season 0 2.7 6.0 8.1 30.8
Traffic 19
Whole year 0 1.2 1.8 2.3 7.4
Warm season 0 1.3 1.8 2.3 5.0
Cold season 0 1.2 1.9 2.4 7.4
Soil and Road dust 10
Whole year 0 0.5 1.0 1.2 10.7
Warm season 0 0.6 0.9 1.2 6.0
Cold season 0 0.4 1.0 1.2 10.7
Coal / Oil combustion 6
Whole year 0 0.2 0.5 0.7 11.3
Warm season 0 0.2 0.4 0.6 3.1
Cold season 0 0.3 0.5 0.8 11.3
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Appendix Table 5. Percent change in cardiovascular mortality among adults for an Interquartile change in 
ultrafine particles, PM2.5, coarse particles, and ozone during the whole year and by season in 1998–2004 in 
Helsinki.
Whole year Warm season Cold season
N = 3 029 N = 1 292 N = 1 737
% 
change 95% CI
% 
change 95% CI
% 
change 95% CI
UFP
Lag 0 0.82 –4.46 6.40 0.63 –3.46 4.90 0.37 –6.82 8.12
Lag 1 –2.64 –7.66 2.65 –2.05 –5.97 2.04 –0.35 –7.07 6.85
Lag 2 –4.69 † –9.51 0.39 –3.64 –7.42 0.30 –3.03 –9.42 3.81
Lag 3 –3.26 –8.04 1.77 –2.53 –6.27 1.36 –1.39 –7.75 5.41
Lag 4 –1.40 –6.19 3.63 –1.08 –4.81 2.79 1.65 –4.78 8.50
Lag 5 0.43 –4.35 5.45 0.33 –3.37 4.18 4.29 –2.15 11.2
PM2.5
Lag 0 1.18 –2.06 4.54 –0.20 –6.91 7.00 2.63 –1.24 6.64
Lag 1 –0.89 –4.07 2.39 –5.70 –11.6 0.60 1.66 –2.18 5.65
Lag 2 –1.50 –4.65 1.76 –3.01 –8.92 3.28 –1.02 –4.87 3.00
Lag 3 –3.67 * –6.84 –0.40 –7.97 * –13.7 –1.83 –2.08 –5.97 1.96
Lag 4 –1.50 –4.65 1.75 –5.68 † –11.2 0.22 0.77 –3.09 4.77
Lag 5 –0.50 –3.65 2.75 –6.80 * –12.2 –1.05 3.11 –0.71 7.06
Coarse PM
Lag 0 –0.77 –4.40 3.01 –6.35 –14.9 3.11 2.16 –2.21 6.72
Lag 1 –1.39 –4.95 2.31 –1.40 –9.87 7.87 –0.03 –3.96 4.06
Lag 2 –3.37 –6.94 0.35 –4.82 –13.0 4.13 –2.49 –6.45 1.64
Lag 3 –2.06 –5.50 1.51 –10.6 * –18.3 –2.23 0.63 –3.15 4.55
Lag 4 –1.68 –5.01 1.77 –8.83 * –16.4 –0.57 0.59 –3.17 4.50
Lag 5 –3.20 –6.56 0.29 –11.6 * –18.9 –3.66 –0.38 –4.25 3.64
O3
Lag 0 –3.35 –10.2 4.06 4.44 –7.85 18.4 –8.32 † –17.0 1.28
Lag 1 –2.07 –8.63 4.95 6.90 –3.79 18.8 –7.82 † –16.1 1.31
Lag 2 1.75 –4.76 8.70 1.63 –8.08 12.4 1.11 –6.98 9.91
Lag 3 –0.52 –6.67 6.05 –3.55 –12.3 6.11 1.46 –6.87 10.5
Lag 4 –3.70 –9.56 2.53 –0.61 –9.33 8.94 –6.71 –14.2 1.44
Lag 5 –3.03 –9.10 3.45 –2.01 –11.2 8.15 –4.21 –12.0 4.32
*  p < 0.05
†  p < 0.10
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Appendix Table 6. Percent change in all respiratory hospital admissions of children for an Interquartile 
range increase in ultrafine particles, PM2.5, and coarse particles by season in 1998–2004 in Helsinki.
Whole year Warm season Cold season
N = 2 147 N = 894 N = 1 253
% 
change 95% CI
% 
change 95% CI
% 
change 95% CI
UFP
Lag 0 0.78 –1.96 3.60 –0.68 –6.27 5.24 2.06 –1.42 5.66
Lag 1 0.74 –1.93 3.48 2.68 –3.19 8.92 –0.01 –3.18 3.28
Lag 2 –0.25 –2.88 2.46 –2.86 –8.34 2.96 0.09 –2.97 3.25
Lag 3 0.32 –2.22 2.93 –1.74 –7.29 4.16 0.07 –2.97 3.20
Lag 4 –0.49 –2.92 2.01 0.96 –4.72 6.98 –0.79 –3.78 2.29
Lag 5 –2.20 † –4.57 0.23 0.77 –4.76 6.62 –3.55 –6.47 –0.54
PM2.5
Lag 0 2.15 * 0.36 3.97 4.25 † –0.13 8.83 1.42 –0.49 3.37
Lag 1 2.01 * 0.29 3.77 4.87 * 0.69 9.22 1.34 –0.53 3.24
Lag 2 0.40 –1.32 2.14 –2.03 –6.01 2.13 0.79 –1.07 2.68
Lag 3 0.20 –1.52 1.94 –0.38 –4.26 3.67 0.23 –1.64 2.14
Lag 4 –1.48 –3.15 0.22 –4.65 –8.16 –1.02 –0.58 –2.45 1.32
Lag 5 –1.48 –3.11 0.19 –4.36 –7.67 –0.93 –0.38 –2.24 1.51
Coarse PM
Lag 0 1.70 –0.21 3.63 2.45 –1.41 6.47 2.39 * 0.29 4.54
Lag 1 0.46 –1.43 2.40 3.73 * 0.04 7.55 0.36 –1.74 2.51
Lag 2 1.24 –0.64 3.16 0.69 –3.01 4.54 2.24 * 0.12 4.40
Lag 3 0.21 –1.62 2.07 –0.56 –4.18 3.20 1.14 –0.87 3.20
Lag 4 0.58 –1.18 2.37 0.39 –3.09 3.98 1.33 –0.59 3.27
Lag 5 –1.03 –2.77 0.75 –0.08 –3.43 3.37 –0.42 –2.33 1.52
*  p < 0.05
†  p < 0.10

